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ABSTRACf

The problem addressed by this dissertation is the separation of
optical isomers in commercial as well as biological samples. The
chromatographic separation of enantiomers is an important and rapidly
developing field of study.
Chiral separations of pharmaceutical compounds and
important organic intermediates in high performance liquid
chromatography (HPLC) and thin layer chromatography (TLC) were
achieved. Two methods were employed for the direct liquid
chromatographic resolution of chiral analytes: chiral stationary phases
(CSPs) and chiral mobile phase additives (CMAs). Native and derivatized
J3-cyclodextrins (J3-CD) were used as chiral stationary phases in reverse
phase and normal phase HPLC, respectively. This study marked the first
use of derivatized J3-CDs for chiral separations in normal phase media. Ncarbobenzoxy-glycyl-L-proline and (lR)-(-)-ammonium-10camphorsulfonate were utilized as CMAs in normal phase TLC for the
resolution of several aromatic amino alcohols. Maltosyl-J3-CD and
hydroxypropyl-J3-CD were employed as CMAs in reverse phase TLC. A
study was conducted with hydroxypropyl-(3-CD to determine how the
degree of substitution of a derivatized CD could effect development time,
the viscosity of the solution and the enantioselectivity.
In addition, studies were initiated to determine the presence of
trace levels of D-amino acids in: amniotic fluid, blood serum and urine.
The blood and urine of healthy young adults were analyzed and found to
contain trace to percent levels of D-amino acids. The human amniotic fluid
samples did not have detectable levels of D-amino acids.
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I. INTRODUCTION

A substantial amount of research has been conducted in the area of
chiral separations due to the demand for efficient, precise and dependable
methods for the determination of optical purity and/or preparative scale
separation of optical isomers (enantiomers). One reason for this effort is
the fact that two enantiomeric forms of a molecule can have different
effects in biological systems ( 1), and as the need for information on the
often widely variant activities of enantiomers of pharmacologically
important compounds increases, the demand for chiral separation methods
will continue. Differences in biological activity of drugs, agrochemicals,
etc., may originate due to dissimilarities in: protein binding and transport,
mechanism of action, metabolism rates, changes in activity due to
metabolism, clearance rates, and persistence in the environment. Another
important use for enantioselective separations is to check reaction progress
and purity (% composition of each enantiomer, quality control, etc.)
during asymmetric syntheses.
The chromatographic separation of enantiomers is an important and
rapidly developing field of study. There has been a dramatic increase in
the number and nature of racemic separations obtained by chromatographic
methods. The development of fast and productive chiral separation
methods continues to escalate. These separation methods involve the use of
chiral counter ions/chiral mobile phase additives (CMA) in thin layer
chromatography (TLC) and high performance liquid chromatography
(HPLC), and of chiral stationary phases (CSP) in TLC, HPLC and gas
chromatography (GC).
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Consequently, manufacturers in pharmaceutical, pesticide, and food
and beverage industries now have the means to tailor the preparation of
products which contain optically active compounds. It has been reported
that approximately 57% of the active pharmaceutical compounds
prescribed in the United States contain at least one stereogenic center (2,
3). The biological activity of two enantiomeric forms of an active drug
can be significantly different. For example, it was found that the L-form
of thalidomide is a powerful teratogen and the D-form is a sedative and
soporific drug (4, 5). The administration of the racemate D, Lthalidomide to pregnant women during the 1960's was associated with a
large number of newborn abnormalities. This drug was withdrawn from
the market a few years later. Another example of a drug which exhibits
enantioselective biological activity is propranolol. Propranolol is a (3adrenergic blocker. The (S) enantiomer of propranolol is about 100 times
as potent as the (R) isomer (2, 6). Such differences in pharmacological
activity between enantiomers is often the rule rather than the exception.
However, in the period 1983-1985, 88% of the new chiral drugs
introduced were marketed as racemates (3). Many individuals believe that
racemic pharmaceuticals will soon be considered as drugs with 50%
impurity (2, 3, 5).
Regulatory authorities have begun requesting data on stereochemistry
as knowledge of the biological importance of chirality increases. The
awareness that the efficacy and toxicology of enantiomers may differ from
each other and from the racemic mixture continues to grow. Studies
indicate that metabolism can produce chiral metabolites from non-chiral
molecules (7). Some reaction examples are shown in Figure 1.
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Figure 1. Examples of reactions which could ·produce chiral metabolites
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Recently, the Food and Drug Administration (FDA) has issued
guidelines on the submission of New Drug Applications (NDAs) which
addresses the question of stereochemistry in the manufacturing of drug
substances (8). The Food, Drug and Cosmetic (FD & C) Act requires a
complete description of the "methods used in the manufacture of the drug"
which includes testing to demonstrate its identity, strength, quality and
purity. Consequently, the decision of whether to market the racemate in
preference to a pure enantiomer must now be justified by the submission of
relevant information.
The significance of stereoisomerism in relation to biological activity
has been recognized since Pasteur reported the first separation of
enantiomers. The question to be answered was 'Why are living systems
chirally discriminating?'. The answer was that living systems are
composed of chiral molecules. Therefore the human body is a highly
stereospecific environment and in nature, biological asymmetry at the
molecular level is the norm, not the exception.
All naturally occurring amino acids are L-amina acids and most
natural sugars are D-sugars. There are twenty primary protein
constituents which consist of 19 L-a-amino acids and one cyclic L-a-imino
acid, proline (9). Phospholipids, steroids, nucleotides, nucleosides, and bile
salts are other examples of chiral molecules of biological necessity.
Over 50 years ago Kogl and Erxleben (10) reported the presence of
D-amino acids in the hydrosylates of tumor proteins. Although most other
investigators believed that the D-amino acids were produced via
racemization during the acid hydrolysis step, the controversy went on for
over a decade (11, 12). Currently, there is not a lot of conclusive evidence
for the occurrence of D-amino acids in the proteins of man. However,
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there is undisputed evidence for the occurrence of both free and bound Damino acids in a variety of micro-organisms (13). Given the central
importance of amino acids in all living systems and their use in the
diagnosis of certain disorders or diseases in man, it seems logical to
investigate all possible aspects of these compounds
Amino acid analysis has been used in biochemistry for the
determination of free amino acids and to study proteins, i.e.,- purity,
quantitation, composition, sequencing, etc. The separation of amino acids
on cation exchange resins has been the preferred technique for their
quantitation in both hydrosylates and physiological fluids since the classic
studies of Moore and Stein (14, 15). The ease of quantitation was greatly
enhanced by the development of the automatic analyzer (16). Although
ion-exchange chron1atography has been the main method for amino acid
analysis, recently the technology associated with HPLC has been applied
with increasing success. The comprehensive studies on the
chromatography of amino acids performed by Hamilton (17 :-19) in the late
1950s was echoed in HPLC literature. Modem HPLC equipment has
recently achieved the level of sophistication which was standard in amino
acid analyzers a decade ago. It should be emphasized that ion exchange
chromatography of amino acids depicts one specific application of the
general analytical procedure of liquid column chromatography and that
high performance (or high pressure) liquid chromatography is the
terminology applied to the technique as currently optimized.
The interest in HPLC lies in the speed, economy, and ease of this
technique in comparison to that of conventional ion-exchange methodology.
The development of HPLC technology for amino acid analysis is lacking
for underivatized samples but it is possible to attain fast sensitive
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separations for many amino acid derivatives (20, 21 ). There have been a
few reports in the literature concerning the analysis of free amino acids
using reversed-phase HPLC (22). Nonpolar stationary phases have been
successful in attaining separations of underivatized amino acids but the
resolution is not comparable to that obtained in conventional ion-exchange
chromatography.
Resolved samples of chiral amino acids are now required for the
majority of amino acid analyses. Chiral amino acids can be obtained from
the following: (a) natural source, (b) asymmetric synthesis, or (c)
resolution of a D, L amino acid obtained through synthesis.
There are two methods for the direct liquid chromatographic analysis
of chiral compounds: chiral stationary phases and chiral mobile phase
additives. The formation of reversible diastereomeric complexes with the
CMA or the CSP is the basis for the chromatographic resolution of optical
isomers. Enantiomers have identical chemical and physical properties in an
isotropic environment but diastereomers may display dissimilar properties
in isotropic environments; this difference makes it possible to separate
diastereomers. Differences in the distribution properties of the
diastereomeric complex may be due to differences in the binding strength
to the adsorbent and/or to dissimilarities in the complex solvation or
solubility in the mobile phase.
There have been several reports on using CMAs in chromatographic
analysis. Numerous racemic mixtures can be resolved on conventional
achiral LC columns by utilizing the proper chiral additive in the mobile
phase. The first to report this beneficial innovation were Gil-Av and coworkers (23) and Karger and associates (24) utilizing ligand exchange
chromatography (LEC). In LEC, a transition metal ion such as Cu(II) or
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Zn(II) must be added to the mobile phase. The CMA consisted of a chiral
bidentate ligand with a hydrophobic moiety. The ligand strongly associates
with the reverse-phase media due to its hydrophobic segment. Suitable
racemic analytes, particularly amino acids, form ternary complexes which
are retained by the stationary phase.
Chiral separations have also been obtained using suitable CMAs with
achiral stationary phases in reversed-phase (25) and normal-phase (26)
modes. The selectivities of these CMAs sometimes differ from those of
available CSPs. Most of the recent work done in normal phase HPLC
involved the use of chiral counter ions. Pettersson and Schill reported the
separation of enantiomers by "ion-pair" chromatography using quinine,
camphorsulfonic acid, albumin, and n-dibutyl tartrate as chiral counter ions
(27). Pettersson and Josefsson reported the separation of racemic
aromatic amino alcohols in ion interaction chromatographic systems using
N-carbobenzoxy-glycyl-L-proline (ZGP) (28). Knox and Jurad reported
the separation of optical isomers by zwitterion-pair chromatography; the
chiral agent in this case was L-leucyl-L-leucyl-L-leucine (29).
Research involving the use of CMAs in HPLC has revealed several
important parameters: the nature of the solid phase, the concentration and
nature of the CMA and the amount of polar modifier in the mobile phase
(27). Consequently, the use of CMAs is a viable but relatively unexplored
approach to chiral separations.
Cyclodextrins (CD) have proven useful as chiral stationary phases
(CSPs) and as chiral mobile phase additives (CMAs) but their low solubility
in hydro-organic solvents has limited their applicability as CMA in the
reversed-phase (RP) mode. The solubility of B-CD in pure water is 1.67 x
1Q-2 M at 250 C. Chiral resolution was attained only when the
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concentration of ~-CD was increased to levels surpassing its solubility in
neat water. Two approaches have been used to overcome the solubility
problem. One approach takes advantage of the fact that it is possible to
increase the solubility of the native CD by the addition of urea or sodium
hydroxide to the mobile phase (30). Aqueous solutions saturated with urea
were more effective in attaining chiral separations than aqueous solutions
containing sodium hydroxide. The proposed separation mechanism for the
native COs in the reversed-phase mode involved the formation of an
inclusion complex, driven by hydrophobic interactions, in which each
enantiomer is complexed somewhat differently in the CD cavity. Disparate
retention times are noted for the optical isomers. The relative size and
geometry of the guest molecule in relation to the dimensions of the host CD
cavity are important parameters in determining if an inclusion complex can
be formed (31 ). Other parameters include: the concentration of the CMA,
the concentration and the type of organic modifier in the mobile phase, and
the retention behavior of enantiomers.
Another approach benefits from the enhanced solubility of derivatized
cyclodextrins in hydro-organic solvents relative to that of the native CD.
The derivatization process involves the formation of ethers due to the
addition of propylene oxide to the hydroxy groups on the mouth and base
of the CD cavity. Armstrong, Faulkner, and Han separated a variety of
racemic compounds using hydroxypropyl- and hydroxyethyl- derivatized
~-CD

as CMAs (32).

The majority of reports of CD as a CMA are for TLC whereas most
applications of CD-CSPs are for work in HPLC or GC. Although many
compounds separate well with both methods, it is interesting to note that
sometimes there is a poor correlation between the enantiomeric separations
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obtained with CD-CMA versus CD-CSP. Reasons for this discrepancy may
be: (1) ~-CD is linked to the silica gel via an 6-10 atom spacer and these
spacer arms may provide additional interaction sites for the complexed
analyte and/or these arms may restrict motion of the CD; (2) if the CD is
in the mobile phase, it is available for multiple complexation. The most
notable difference that has been observed between the use of CD as CMA
and CSP in reversed-phase media is the reversal of elution order of
enantiomers. For example, with DL amino acid derivatives, the D
enantiomer elutes ahead of the L enantiomer when the chiral agent is in the
mobile phase but a reversal of the retention behavior is noted if the chiral
selector is bonded to the stationary phase, exclusively (30).
Cyclodextrin bonded phases have been used for the reversed phase
separation of a variety of enantiomers (33), diastereoisomers (34),
structural isomers (34 ), enzymes (35), and routine compounds (36). Of
these, the enantiomeric separations probably have received the greatest
attention. In order to evaluate the mechanism of enantioselective
chromatography, a number of empirical and theoretical studies have been
done (37 -41 ). In specific cases involving cyclodextrins, the formation of
an inclusion complex seems to be a fundamental part of the chiral
recognition and separation process (33, 34, 36, 41). As yet, there have
been no reports of normal phase, enantiomeric separations on native
cyclodextrin bonded phase columns. Indeed, the fact that facile
enantiomeric resolution obtained in the reversed phase-mode could not be
duplicated in the normal phase-mode has been used as indirect evidence to
support the premise that inclusion complexation is necessary for
enantioselectivity (41 ). However, native cyclodextrin bonded phases have
been used successfully in nonnal phase LC for a number of achiral
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separations (42-44 ). The retention behavior was somewhat like that of a
diol column. It is believed that the nonpolar portion of the mobile phase
(e.g., hexane, heptane, etc.) occupies the cavity of cyclodextrin and that
solute retention was due mainly to interaction with the external hydroxyl
groups that line the top and bottom of the cyclodextrin torus (42-45).
Among the available CSPs for LC are the polymeric chiral phases
(46), the crown ether phases (47), the protein CSPs (48, 49), the

1t-

complex, hydrogen bond CSPs (Pirkle-type) (50), and the cyclodextrin
(CD) bonded CSPs (33). The number of commercially available HPLCCSP has risen to over fifty and has continued to grow annually (51). There
have been several reviews of HPLC-CSPs which were designed to help
determine which CSP to use for a particular problem (52-56). It should be
noted that research has concentrated on HPLC while the progress in TLC
has advanced much more slowly.
There have been relatively few reports of CSP for TLC and only for a
limited number of compounds. Yuasa announced the partial separation of
D, L-tryptophan on a crystalline cellulose-coated plate (57). Wainer, eta/.
published the separation of racemic 2, 2, 2-trifluoro-1-(9-anthryl)ethanol
on a chiral dinitrobenzoylphenylglycine bonded phase (58). Brunner, eta/.
reported the use of a naphthylethylurea TLC-CSP for the separation of
enantiomeric amides (59). Alak and Armstrong published the separation of
several racemic amino acids and ferrocene derivatives on a
bonded phase (60). While

~-CD

~-cyclodextrin

was used successively as a bonded TLC

phase, attempts to coat a TLC plate with

~-CD

were unsuccessful (61).

The problem with coating the plates was due to the low solubility of ~-CD
in organic solvents. Weinstein (62), Grinberg and Weinstein (63), and
Gunther, et al. (64) reported the separation of several racemic dansyl

I1

amino acids on reversed-phase (RP) plates impregnated with copper (II)
complexes of chiral alkyl a-amino acid derivatives. Results obtained with
TLC-CSPs are comparable to those obtained using analogous HPLC-CSPs.
At this time, the only CSPs which are commercially available for TLC are
the ternary complex-ligand exchange plates. Some of the problems in
developing chiral TLC plates were discussed by Wilson (61).
Several important differences exist between HPLC and TLC. The
major advantage that HPLC has over TLC is better reproducibility, greater
sensitivity and more theoretical plates. The fact that the HPLC column is
equilibrated with the mobile phase before use whereas the TLC stationary
phase is initially dry has resulted in several important differences. The
quantity of mobile phase in the bed varies according to location on the TLC
plate, such that the phase ratio varies during development. Second, heat is
given off when a solvent wets a dry bed and this results in a small
temperature differential between the solvent front and the rest of the bed.
Third, in TLC, the mobile phase may change composition during
development of a binary or more complex solvent due to differential
adsorption on the stationary phase. In addition, the velocity of the solvent
front is inversely proportional to the distance that the solvent front has
traveled, so the flow rate is not constant with time or distance. Also, the
amount of chiral agent in the mobile phase may change with TLC due to
preferential adsorption of the chiral selector as the solvent front migrates
along the chromatographic bed. In contrast, the concentration of the CMA
remains constant during high performance liquid chromatographic analysis
due to pre-equilibration of the LC column.
An advantage of HPLC is that the analyst can choose between gradient
or isocratic elution. It is also possible to change the flow rate in HPLC to
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optimize separations. Precise control of pH and ionic strength during the
separation process and ease of temperature control are additional
advantages offered by high performance LC. Despite these differences, it
is sometimes possible to attain similar results with both chromatographic
methods.
TLC has achieved popularity due to its simplicity, low cost and wide
versatility and applicability. In his review, Stahl stated that TLC was the
easiest and most economical chromatographic technique for fast separation
and visual evaluation (65). The main advantage of TLC over HPLC has
been the ability to screen a large number of compounds concurrently
thereby saving time and operating expenses. One problem that has been
noted is t!·;c elongation of spot size and/or irregular spot size for polar
compounds using this method. The introduction of high performance TLC
has helped this problem somewhat. The spot diameter is controlled by
molecular diffusion in high performance plates (66). In some cases, TLC
could be used to determine what mobile phase to use in HPLC if the same
CSP or CMA was utilized. In the case of enantioselective synthesis, it
could provide useful information as to the progress of a reaction.
Theoretically, it is possible to choose the mode which best suits the
needs of the analyst. The main obstacle to this idea has been the limited
commercial availability of CSPs for TLC. Although there are a greater
number of commercially available CSPs for HPLC, these columns can be
expensive and may be easily damaged. A viable alternative to CSP is the
use of achiral stationary phases with the appropriate CMA. Some
disadvantages of using CMAs are: ( 1) the isolation of a pure chiral analyte
may be difficult, and (2) the method of detection must be compatible with
the CMA used. For example, if a compound which absorbs ultraviolet
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light is used as a CMA, one can use an ultraviolet detector in HPLC and
adjust the baseline accordingly but in TLC it would not be possible to
detect the samples using an ultraviolet detector. Advantages of using CMA
are: (1) it is easy to change the chiral selector being used, and (2) the
lifetime of conventional achiral columns is typically longer than that of
chiral columns.
In this dissertation, the use of various CMAs and CSPs in TLC and

HPLC for the resolution of chiral analytes will be discussed. A method for
the TLC separation of enantiomers and diastereomers involving the use of
chiral ion interaction agents will be described. Several aromatic amino
alcohols were resolved by TLC using a mobile phase containing (1 R)-(-)ammonium-1 0-camphorsulfonate or N-carbobenzoxy(CBZ)-glycyl-Lproline (ZGP). Many of these chiral aromatic amino alcohols are of
pharmacological importance as a- and

~-adrenergic

blockers, adrenergic

compounds, and anti-glaucoma agents. A comparison was made between
various N-CBZ-amino acid derivatives as chiral counter ions/chiral mobile
phase additives. Various mobile phase compositions and numerous
commercially available achiral TLC stationary phases were evaluated.
Amino acid derivatives, nicotine derivatives and cinchona alkaloids
were separated by thin layer chromatography on different types of
reversed phase plates using a mobile phase containing

maltosyl-~

cyclodextrin. A comparison is made between octadecyl, diphenyl and ethyl
reversed-phase TLC plates. Several derivatized amino acids are separated
by thin layer chromatography utilizing hydroxypropyl -~-cyclodextrin (HP~ -CD).

Studies were conducted to determine the effect that the degree of

substitution of HP-~-CD would have on: the resolving abilities of the
CMA, the time of development and the viscosity of the hydroxypropyl-~-
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CD mobile phase solutions. Comparisons will be made between the native
and the derivatized CD used as CMAs in RP-TLC.
The separation of some drug stereoisomers using native CD CSPs and
hydroorganic mobile phases will be presented. The principal features of
the CD chiral recognition mechanism will be reiterated. In addition,
several different derivatized f3-cyclodextrins were synthesized and used as
chiral stationary phases in normal phase liquid chromatograph y. The
multiply substituted derivatives were made with acetic anhydride, (R)- and
(S)-1-(1-napht hyl)ethylisocy anate, 2,6-dimethylphenylisocyanate and ptoluoyl chloride. The first successful cyclodextrin-based, normal phase
separation of enantiomers was accomplished on these derivative phases. In
contrast to chiral separations on the native

~-cyclodextrin

stationary phase,

the enantiomeric separation mechanism on these new phases in the normal
phase mode was not thought to be dependent on inclusion complexation.
The similarities and differences between the derivatized cyclodextrin
stationary phases and the derivatized cellulosic stationary phases will be
discussed.
Analysis of free form amino acids in commercial samples and various
physiological fluids was conducted. Detectable levels of free D-amino
acids were found in human urine and blood serum but not in human
amniotic fluid. This was accomplished using a liquid chromatograph ic
coupled column (i.e ., achiral-chiral) method that was developed for the
rapid and sensitive analysis of these compounds. The technique was tested
on a series of commercial L-amino acids. Care was taken to minimize
racemization. Trace to percent levels of contaminating D-enantiomers

were found in all commercial samples. In urine the D-amino acids ranged
from several hundredths of a percent up to percent levels of the
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corresponding excreted natural L-amino acids. There were no apparent
correlations between the amount of amino acids excreted and the relative
amount of D-enantiomers present. In blood serum samples, the D-amino
acids ranged from less than 0.05% to 0.50% levels of corresponding
natural L-amino acids. The limit of detection for the amino acids in the
analyzed physiological fluids was 0.05%.
It was possible to analyze four amino acids (phenylalanine, tyrosine,
tryptophan and leucine) in urine. In blood serum, three out of four of the
above-mentioned amino acids were analyzed. The majority of the
tryptophan in the blood sample was lost during the solid phase extraction
step. Four amino acids (phenylalanine, tyrosine, leucine and methionine)
were analyzed in the human amniotic fluid samples.

I6

II. BACKGROUND

A. History of Chiral Separations

Stereochemistry is that part of science which deals with structure in
three dimensions. One aspect of stereochemistry is stereoisomerism:
isomers which differ only in the way that the atoms are oriented in space.
Stereoisomers which rotate plane polarized light are called optical isomers.
In 1815 the French physicist, Jean-Baptiste Biot, found that a quartz

rotated plane polarized light (67). This was the first report of optical
activity. However, it was not until 1848 that the first deliberate separation
of enantiomers from a racemic mixture was reported (68). In 1848 at the
Ecole normale in Paris, a young chemist made a set of observations which
led him to make a proposal that now forms the foundation of
stereochemistry. This young man, Louis Pasteur, has just won his
doctorate in science and he was attempting to gain some experience in
crystallography. He was duplicating earlier work on tartaric salts when he
noticed something no one had perceived before: optically inactive sodium
ammonium tartrate consisted of a mixture of two distinctive types of
crystals. Figure 2 depicts the two types of sodium ammonium tartrate
crystals. Pasteur was able to separate the morphologically different
crystals by hand using a hand lens and a pair of tweezers. While the
original mixture was optically inactive, each set of crystals was found to be
optically active in aqueous solution. Furthermore, all physical and
chemical properties of the individual solutions were identical except the
specific rotations of the two solutions which were equal but of opposite
sign. Pasteur's method of mechanical separation demonstrated the
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(+)·form

(-)·form

Sodium ammon1um tanrate

Figure 2. Configuration of sodium ammonium tartrate crystals. Racemic
sodium ammonium tartrate forms two sets of crystals, distinguished by the
non-superimposable mirror-image relation of their crystal facets and the
opposite sign of their optical activity.
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human ability to distinguish left from right, by explicit or implicit
reference to a chiral object, such as a hand. Thus was coined the phrase
"right- or left-handedness". Pasteur concluded that molecular disymmetry
was necessary for optical activity in small molecules or crystals since the
difference in optical rotation was observed in solution. He proposed that
the molecules composing the crystals were mirror images of each other but
he was unable to determine why a molecule would be disymmetric or
chiral.

In 1874, van't Hoff and LeBel individually reported that the
"asymmetric carbon atom" was the reason for chirality (69, 70). Van't
Hoff elucidated the correct proposed structure, tetrahedral rather than
square pyramidal, so he was given the lion's share of the credit for this
discovery (See Figure 3). It is now known that other types of chirality
exist. It is possible to have "chiral centers" as well as "chiral axes" and/or
"chiral planes" of symmetry. Some examples of chiral molecules which do
not contain "chiral centers" are shown in Figure 4. Also, organic
molecules can contain "chiral heteroatoms" such as nitrogen or
phosphorous. Recently it has been proposed to use the term stereogenic
center rather than "chiral center" or "chiral atom" since, technically, an
atom or point cannot be chiral.
There are two different conventions for the designation of the three
dimensional structure of a chiral entity. The first system was devised by
Emil Fisher in his attempt to interrelate the absolute stereochemistry of
optical isomers (71 ). In the late 1880's, Fisher arbitrarily assigned the
absolute configuration of (+)-glucose and the Fisher projection scheme
forms the backbone of present day carbohydrate chemistry. A Fisher
projection of D, L -glyceraldehyde is shown in Figure 5. In 1902, Fisher
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Tetrahedral
Figure 3. Square pyramidal and tetrahedral structure
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Figure 5. Fisher projection of D, L-glyceraldehyde
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was honored for his groundbreaking work by becoming a Nobel Prize
recipient. The D, L system devised by Fisher is still used to describe
amino acids, sugars and their derivatives.
Another useful procedure for designating the spatial structure of
molecules involved the use of the prefixes RandS. These prefixes were
assigned according to a procedure devised by R. S. Cahn, Sir Christopher
Ingold and V. Prelog. There is no essential connection relating the D, L
and the R, S conventions. The D, L convention was based on Fisher
projections whereas the R, S convention was based on Cahn-Ingold-Prelog
sequence rules.
The designation (+) and (-) indicated the direction of specific rotation
of plane-polarized light. If the rotation of the plane of light was to the
right, the substance was dextrorotatory (d) or (+); and if the direction of
rotation was to the left, the substance was levrorotatory (1) or (-). The
symbols d and 1 could also be used to designate the direction of specific
rotation.
When Fisher reported his Nobel Prize work, there was no method for
the determination of absolute configuration so he arbitrarily assigned his
D, L symbols. It was not possible to answer the question of absolute
configuration until 1951 (72). 1. M. Bijvoet reported the determination of
the actual spatial arrangement of atoms of an optically active compound,
d( + )-Na Rb tartrate, using x-ray crystal analysis. Luck was with Fisher for
he had arbitrarily assigned the correct configuration for L-glyceraldehyde.
Ever since Pasteur's pioneering work, investigators have searched for
improved methods to resolve and purify enantiomers. There are several
methods for resolution of enantiomers. These are: (a) conversion to
diastereomers, (b) biochemical processes, (c) mechanical separation, (d)
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differential reactivity, (e) selective crystallization, and (f) differential
adsorption. The dominant approach has been conversion of enantiomers to
diastereomers followed by crystallization. Most of these methods were
characterized by multiple steps and low efficiency. The introduction of
chromatography as a separation tool allowed for efficient enantiomeric
separations. This work focuses on chiral separations that use differential
adsorption properties of enantiomers and/or diastereomeric ion-pairs in a
process known as chromatography.

In 1903, the first application of differential adsorption in a flowing
system with a mobile phase and a stationary phase to separate analytes was
reported by Tswett (73). He passed an organic solvent solution of plant
pigments through a glass column packed with finely divided inulin (a
polysaccharide) and observed the formation of several sharply defined
colored bands or zones. The pigments were separated due to differing
abilities to adsorb upon the inulin thereby creating the colored bands noted
by Tswett. This process was referred to as chromatography.
Chromatography means the production of a color scheme or to write
in colors. This technique, introduced by Tswett, is known as adsorption
chromatography. It operates on a principle which depends upon the
differential adsorption characteristics of analytes in a system composed of a
solid stationary phase and a liquid mobile phase. The behavior of the
analytes is affected primarily by the selection of solid adsorbent and
solvent.
In the beginning, there was only one type of chromatographic
technique available for the scientist, this involved a polar stationary phase
and a nonpolar mobile phase. Also, it was only possible to analyze colored
substances. Many methods were utilized to adapt adsorption
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chromatography to the analysis of colorless compounds. The formation of
colored derivatives (74) and the use of dyes (75) proved successful.
As technological advances were made in the twentieth century,
instrumentation was developed to enhance the capabilities of
chromatography. There are now a wide variety of commercially available
detectors which allow detection of unlimited numbers of compounds.
Derivatization of analytes is now used as often to enhance separation as for
detection. Tswett used a glass column and the flow through the column
resulted from gravitational force. Modern liquid chromatography uses
microbore columns capable of withstanding pressures up to several
atmospheres and mechanical pumps are used to maintain a designated flow
rate.
In addition to changes in technology, scientists were discovering new
applications and methodology based on Tswett's early findings . Research
by Martin marked the beginning of modem paper chromatography (76).
The first gas chromatography paper appeared in 1951 (77). Stahl reported
the first use of thin-layer chromatography five years later (78). Liquid
chromatography emerged on a comparable basis to gas chromatography
with the introduction of work by Huber and Hulsman (79). Halasz and
Sebastian reported the first chemically bonded stationary phases for liquid
chromatography (80). With the introduction of bonded stationary phases,
it became necessary to denote the original polar stationary phase/nonpolar
mobile phase method as the nonnal-phase mode and the newer nonpolar
stationary phase/polar mobile phase approach as the reverse-phase mode.
The literature contains references dating as far back as 1904 which
catalog attempts to resolve racemic compounds using adsorption methods
(81 ). A review of early chromatographic literature indicates that the first
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complete resolution of enantiomers was achieved on paper
chromatography. In 1939, Henderson and Rule reported the chiral
separation of d, 1-p-phenylenediiminocamphor on d-lactose (82). Kotake,
et. al., researched the influence of a chiral mobile phase on the resolution
of several amino acids in paper chromatography in 1951 and he ascribed
the separation to the chirality of the support, cellulose (83). In 1952,
Dalgliesh proposed that a three-point simultaneous attachment was
necessary to resolve amino acids using a cellulosic surface, this model was
later modified to include additional interactions, such as repulsion and/or
steric hindrance (84 ). Figure 6 shows a simplified model of a three-point
interaction between chiral molecules.
Another polysaccharide, starch, was used by Prelog et. al. to separate
Troger's base (85) and by Krebs et. al. (86) to resolve various acids. The
first use of a modified chromatographic support for chiral separation was
reported in 1960 (87). Klenn and Reed impregnated silica with a
nitroaromatic entity because such compounds were known to complex
other aromatic hydrocarbons via

7t-1t

interactions.

In the 1960s compounds were derivatized with chiral reagents to form
diastereomers and then chromatographically analyzed. Development of
chiral separation techniques was dominated by gas chromatography during
the 1960's. Gil-Av, et. a!. reported the first successful direct enantiomeric
separation in gas chromatography in 1966 (88). This approach employed
the differential association of enantiomers with a chiral chromatographic
media composed of de~ivatized amino acids. Short-lived diastereomeric
adsorbates which differ in stability were formed. The enantiomer which

fonned the more stable complex was preferentially retained. This idea
forms the foundation for modem chiral stationary phases and would
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Figure 6. Simplified model of three point interaction between chiral
molecules
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eventually lead to the development of a wide variety of chiral LC and GC
chromatographic supports.
In 1968 Rogozhin and Davankov (89) reported that ligand exchange

chromatography (LEC) could be utilized for liquid chromatographic chiral
separations. If a metal was introduced into a system which was capable of
reversibly coordinating with an asymmetric stationary phase and the
individual enantiomers, a complex diastereomeric specie could be
dynamically formed (See Figure 7). Rogozhin and Davankov covalently
bonded amino acids, such as L-proline, to a polystyrene-p-divinylbenzene
cross-linked copolymer support and used copper (II) as the chelating metal
to resolve free amino acid racemates. This method proved to be an
effective technique for separating underivatized amino acids.
A different type of complexation, inclusion complexation, was
reported by Cram and his group (90, 91 ). Cram synthesized various chiral
binaphthyl based crown ethers and discovered that the 18-crown-6 proved
to be a successful chiral stationary phase (47). The chiral crown ether used
as a CSP in this study is shown in Figure 8. It was possible to resolve
chiral compounds which contain primary amines because the 18-crown-6
ether moiety complexes ammonium ions (See Figure 9).
Up to this point, progress in the field of chiral separations was moving
at a slow pace. The 1980s marked a rapid evolutionary period for chiral
stationary phase development and commercialization, followed by global
public acceptance and use. The turning point was marked by the
introduction of the 'Pirkle' bonded phase which was heralded for its wide
applicability and became the first commercialized CSP (50). Pirkle's
rationale in designing a chiral stationary phase was based on the theories of
Dalgleish and Gil-Av. Pirkle tried to create a three point simultaneous
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interaction between the analyte and a chiral bonded molecule via 1t-1t
interactions, hydrogen bonding, and dipolar interactions. The initial
commercial 'Pirkle' CSP consisted of (R)-N-3,5-(dinitrobenzoyl)phenylglycine bonded to y-aminopropylsilanized silica gel. These CSPs can
be used with relatively polar mobile phases, but enantioselectivity and
stability are enhanced in the normal-phase mode. A wide variety of 1tcomplex-hydrogen bond CSPs have been sy1,1thesized by Pirkle and by
other scientists, but the general applicability remains the same (92, 93).
The second generation 'Pirkle' phases have improved enantioselectivity
(37) in comparison to that of the first generation.
In the ongoing search for new and improved CSPs, it is not surprising
to note the continuing adaptation of saccharides as potential CSPs. Linder
and Mannschreck reported the use of triacetyl cellulose as a CSP in 1980
(94). Various derivatized cellulosic phases (See Figure 10) have been
commercialized and have proven successful in separating racemic
thioamides, sulfoxides, organophosphorus compounds, pharmaceuticals and
amino acid derivatives. Another commercially available polysaccharide
stationary phase was developed by Armstrong in 1984 (95). This was the
cyclodextrin bonded phase. A simplified schematic depicting inclusion
complexation between a solute and a native cyclodextrin stationary phase is
shown in Figure 11. Cyclodextrin stationary phases have been utilized
primarily in the reverse-phase mode for the resolution of pharmaceuticals,
nicotine analogues, derivatized amino acids, steroids, metallocenes,
binaphthyl crown ethers and various aromatic compounds. The structural
similarities between cellulose and cyclodextrin are shown in Figure 12.
Another type of commercially available CSP involved natural and
synthetic polymers. In 1981, Okamoto reported the use of a helical
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Figure 10. Cellulose derivatives utilized as chiral stationary phases
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Figure 11. Simplified schematic of inclusion complexation with a native
cyclodextrin
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synthetic polymer, (+)-poly(triphenylmethyl methacrylate) as a chiral
stationary phase (46). This polymer can be used either as solid high
molecular weight polymeric particles or as soluble low molecular weight
fractions which are adsorbed onto diphenyl silanized silica gel. The state
of the polymer can affect the enantioselectivity and the adsorbed version
appears to have a wider applicability. In 1983, two protein bonded LC
phases were reported. Allenmark developed the bovine serum albumin
(BSA) phase (48) and Hermansson produced the a1-acid glycoprotein
(AGP) phase (49). Both of these natural polymeric phases were shown to
be very useful. The BSA column can be utilized to separate derivatized
amino acids, aromatic sulfoxides and certain pharmaceuticals. The AGP
column can resolve a wide variety of cyclic and aromatic drugs. The
major complaint for the protein bonded phases has been the frailty of these
columns and the inability to do preparative scale separations. The second
generation columns are proving somewhat hardier.
It should be noted that amino acid and chiral crown ether bonded
chiral stationary phases have been commercialized for use with ligand
exchange chromatography and the high performance liquid
chromatography, respectively.
It is important to note that despite the changing face of technology, the
basic principles of adsorption chromatography are still the same. In liquid
chromatography (LC), the adsorption of an analyte is determined by
several parameters: the nature of the solvent, the nature of the adsorbent,
the nature of the analyte, temperature, and pH.
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III. EXPERIMENTAL
A. MATERIALS
1. Thin layer chromatography

Silica gel (K5F, 250 micrometer [J.lm] layer thickness, 5 x 20
centimeter [em]), high performance silica gel (HP-KF, 200 J.lm layer
thickness, 5 x 5 em), cellulose (K2F, 250 Jlm layer thickness, 5 x 20 em),
chemically bonded octadecyl (KC18F, 200 J.lm layer thickness, 5 x 20 em),
chemically bonded ethyl (KC2F, 200 J.lm layer thickness, 5 x 20 em) and
chemically bonded diphenyl (Diphenyl-F, 250 J.lm layer thickness, 5 x 20
em) TLC plates were obtained from Whatman Chemical Separation
Division, Inc. (Clifton, NJ). Aluminum oxide (250 Jlm layer thickness, 5 x
20 em) and diol (HPTLC Diol F254s, 200 j..lm layer thickness, 10 x 10 em)
TLC plates were obtained through Alltech Associates, Inc. (Deerfield, IL).
Phenylpropanolamine, timolol, isoproterenol, metoprolol,
propranolol, octopamine, pindolol, N-carbobenzoxy-alanyl-L-proline, Ncarbobenzoxy-isoleucyl-L-proline, N-carbobenzoxy-L-proline, Ncarbobenzoxy-glycyl-L-proline, dansyl-DL-leucine, dansyl-DL-methionine,
dansyl-DL-norleucine, dansyl-DL-phenylalanine, dansyl-DL-valine,
cinchonidine, cinchonine, quinine, quinidine, heptakis

(2,6-di-0-methyl)-~

cyclodextrin, and sodium chloride were obtained from Sigma (St. Louis,
MO). Norphenylephrine, 1-pentanol, molecular sieves (5 Angstrom, 4-8
mesh), (1 R)-(-)-ammonium-1 0-carnphorsulfonate, DL-alanine-~
naphthylamide,

DL-methionine-~-naphthylamide

and RS-5-(4-

rnethylphenyl)-5-phenylhydantoin were obtained from Aldrich
(Milwaukee, WI). Methylene chloride (CH2CI2), ethylene glycol,
acetonitrile, ethanol, 2-propanol, methanol (MeOH), and !-butanol were
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obtained from Fisher Scientific (Fair Lawn, NJ). N'-(2-naphthylmethyl)nomicotine, a nicotine analogue, was synthesized according to the
following scheme (31).

Scheme 1•

i

H'

~ ii

iv

AI-0
I

H

iii

• i, Lithium diisopropylamide; ii, hydrochloric acid, heat, then
hydroxide; iii, sodium cyanoborohydride; iv, n-butyllithium, then

R2Br.

Maltosyl-~-CD

was supplied by P .C. Hermann. Two different

companies, Pharmatec and Consortium Fur Elektrochemische Industrie
GMBH (Wacker), supplied the

HP-~-CD

for the study regarding the effect

of the degree of substitution. Pharmatec indic(!ted the degree of
substitution (DS) as 2, 7 and 9 for their product. The average molar
substitution (MS) of the

HP-~-CD

supplied by the Wacker company was

0.6 and 0.9. The degree of substitution indicates the number of
substitutents per CD molecule whereas the molar substitution is the number
of substitutents per anhydroglucose unit. The

~-CD

molecule consists of

seven linked glucose units so if the MS was 0.6 for the derivatized CD; the
OS would be 4.2.
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2. High Performance Liquid Chromatography

Huperzine A, a drug under investigation for Alzheimer's dementia
(44), was kindly provided by Professor A. P. Kozikowski and Dr. Yan Xia
of the University of Pittsburgh. SQ 30840 is a drug under investigation at
the Squibb Institute for Medical Research, Princeton (NJ). It was supplied
by Dr. Kimball. Efaroxan, Idazoxan and derivatives are drugs under
investigation at Reckitt & Coleman. They were supplied by N. A. Hyde
(Danson Lane, Kingston-upon-Hull, UK). Flouxetine is a drug under
investigation at Eli Lilly Laboratories (Indianapolis, IN). It was provided
by Thomas L. Jeatran. Ibuprofen was supplied by Eli Lilly. The other
drugs were obtained as previously described (41). Etomidate and
Norgestrel were supplied by Advanced Separations Technologies
(Whippany, NJ). Methanol and acetonitrile were from Fisher Scientific
(Fair Lawn, NJ).
The structures of the solutes, which were obtained from various
sources, are presented in the tables. Hexane and isopropanol were obtained
from Fisher Scientific (St. Louis, MO).
Dinitrobenzoyl chloride, 2,6-dimethylphenylisocyanate, (R) and (S)-1(1-naphthyl)ethylisocyanate and p-toluoyl chloride were obtained from
Aldrich Chemical Company (Milwaukee, WI). The acetylated (3-CD
column was 250 x 4.6 mm column obtained from Advanced Separation
Technologies, Inc. (Whippany, NJ). The chromatographic columns used in
the normal phase HPLC study were synthesized according to the procedure
listed under preparation of bonded phase. The columns were packed by
Tom Beesley at Advanced Separations Technologies, Inc. (Whippany, NJ).
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The perchloric acid, mercaptoethanol, boric acid, o-phthalaldehyde,
and DL-amino acids were obtained from Aldrich (Milwaukee, WI).
Methanol, ethanol and potassium hydroxide were supplied by Fisher (St.
Louis, MO). The L-amino acids were provided by the following
companies: Kodak (Rochester, NY), Lancaster Synthesis (Windham, NJ),
Fluka (Ronkonkoma, NY), Sigma (St. Louis, MO), Spectrum (Gardena,
CA) and Research Plus, Inc. (Bayonne, NJ). All of the samples and mobile
phase solutions were filtered using 0.2 fJ. filters supplied by Alltech
Associates, Inc. (Deerfield, IL).
The chromatographic system was a Shimadzu Gradient System, with
two LC-6A pumps, a SCL-6A gradient controller, and a UV detector,
model SPD-6A. The recorder was the Shimadzu model C-R2AX
integrator. The column dimensions were 25 em x 4.6 mm, i.d. Cyclobond
I bonded with

~-cyclodextrin

(seven glucopyranoside units) from Astec. A

Cyclobond II column bonded with y-cyclodextrin (eight glucopyranoside
units) was also used.
The chromatographic columns used in the urine, blood and amniotic
fluid studies included the Crownpak CR(+) and CR(-) columns supplied by
Michael Henry at J.T. Baker (Phillipsburg, NJ) and 5 fJ. octadecylsilane
(CI8) columns obtained from Advanced Separation Technology
(Whippany, NJ).
The LC system used for the analysis of commercial sources of Lamino acids consisted of a Shimadzu LC-6A pump and CR3A chromatopac
recorder, an ESA (Bedford, MA) Coulochem model 51 OOA detector and
analytical cell model 5011, and a Rheodyne (Cotati, CA) model 7125
injector. Two different chromatographic systems were used for the urine
study. The electrochemical (LCEC) system consisted of two Rheodyne
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injectors (models 7125 and 7010), two Shimadzu LC-6A pumps, a Perkin
Elmer (Norwalk, CT) LC-85B spectrophotometric detector, the abovementioned ESA electrochemical detection system, a Perkin Elmer R100A
recorder and a Shimadzu CR3A Chromatopac recorder. The LC system
which utilized fluorescence detection was made up of the following
Shimadzu devices: two LC-6A pumps, a SCL-6B system controller, a
CR601 chromatopac recorder, SPD-6AV UVNIS spectrophotometric
detector, and a RF-535 fluorescence HPLC monitor. The "fluorescence"
chromatographic system also included a Rainin (San Carlos, CA) model A30-S pump, a Scientific Systems, Inc. (State College, P A) pulse dampener
model LP-21 and two Rheodyne injectors (models 7125 and 7010) for post
column derivatization.
A Labconco (Kansas City, MO) Freeze Dryer model 75018 was used
to concentrate some samples and a Precision Clinical Centricone
manufactured by Precision Scientific Company (Chicago, IL) was used for
centrifugation.

B. METHODS
1. Normal phase TLC
The molecular sieves (Type 5A) were dried for twenty four hours at
three hundred and fifty degrees centigrade and stored in a drying oven at
one hundred and twenty five degrees centigrade. Fifty grams of molecular
sieves were used to dry two hundred and fifty milliliters of solvent. The
solvents were dryed for twenty four hours before use. The TLC plates
were placed in a drying oven at one hundred and twenty five degrees
centigrade for three to four hours and then stored in a dessicator until use.
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It took approximately thirty to forty-five minutes to completely
develop a 5 x 5 em TLC plate. All developments were done at room
temperature (200c) in 6 em internal diameter (i.d.) x 23 em cylindrical
glass chambers. Spot visualization was performed by use of a fixed
wavelength, 254 nm, ultraviolet (UV) lamp. A Schimadzu dual wavelength
TLC scanner (CS-910) was used to measure resolution. Various
wavelengths were scanned to provide supporting evidence as to the validity
of the enantiomeric separation.

2. Reverse phase TLC

Sodium chloride was used to stabilize the plate binder. 0.6M sodium
chloride was added to the mobile phases containing greater than 50% water
by volume. Acetonitrile and methanol were used as organic modifiers.
The plates were developed at room temperature (200c) in 6 (i.d.) x 23
em cylindrical glass chambers. Spot visualization was performed by use of
a fixed wavelength (254 nm) ultraviolet lamp. A Shimadzu dual
wavelength TLC scanner (CS-910) was used to measure resolution in the
HP-(3-CD study.
It took approximately thirty-six to forty-eight hours to completely
develop a 5 x 20 em TLC plate when maltosyl-(3-CD was the CMA. It took
approximately thirty minutes to completely develop a 5 x 20 em TLC plate
when the CMA was dimethyl-(3-CD. The approximate development times
are discussed in the results section for the data obtained when HP-(3-CD
was the CMA.
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3. Amino Acid Study
Prior to using the LCEC systems, voltage scans were run on several
essential amino acids. The following amino acids were chosen for the
LCEC commercial study: cysteine, methionine, ornithine, tryptophan and
tyrosine. The applied voltage for the analysis of cysteine, methionine,
tyrosine, and tryptophan was +0.5 volts. A somewhat better response was
noted for these compounds if the voltage was greater than +0.5 and less
than +0.8 volts but the background current was considered to be too high
(greater than 1 J.l amp). A high background current can have detrimental
effects on the electrodes. Ornithine was analyzed at -0.10 volts.
Before beginning this study, it was necessary to optimize the
separation of enantiomers by modifying the mobile phase conditions, the
flow rate and the column temperature. Cysteine and ornithine elute rather
quickly so the optimum temperature was determined to be

ooc and 10°C,

respectively. The optimum flow rate for these two amino acids was 0.1
ml/min. The mobile phase composition was aqueous perchloric acid (pH =
1.5 or 2.0). Under the stated conditions, it was possible to quantitate the
amount of D-amino acid present without interference from the void
volume peak. Methionine, tryptophan, phenylalanine, and tyrosine had
longer retention times so it was possible to analyze these amino acids at
room temperature. The flow rate for methionine and tyrosine was 0.3
ml/min; for phenylalanine, 0.5 ml/min; and the flow rate for tryptophan
was 0.8 ml/min. The mobile phase composition was 97.5/2.5 aqueous
perchloric acid/methanol (v/v) or 100% pH=2 HCl04 solution for these
three compounds.
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A C 18 column was used to isolate the individual amino acids. The
mobile phase consisted either of 95:5 water:methanol (v:v) or 95:5, 5xl0-3

M HCl04:methanol (v:v). The flow rate was 1.0 or 1.5 ml/min. The
column was at room temperature and the UV detector setting was at 200
nm.
A column switching or coupled column method was used for the
analysis of tyrosine, phenylalanine, tryptophan and leucine in physiological
fluids (Figure 26). Urine specimens taken in the early morning were
preferred as they contained higher overall amino acid concentrations. The
optimum separation conditions for the chiral separation are as listed above
and in the individual figures.
Two different methods of detection were used in the urine study:
electrochemical and fluorescence. The applied voltages for the LCEC
experiments were the same as those listed above. Post column OP A
derivatization of the amino acids was required for fluorescence detection.
The excitation wavelength was 340 nm and the emission wavelength was
450 nm. The Rainin pump was the post column pump for this system. The
OPA solution was prepared as follows. The OPA reagent was prepared by
dissolving 700 mg of o-phthalaldehyde in 15 ml of ethanol. Three hundred
milliliters of mercaptoethanol was added to this solution. The solution was
then added to lliter of 3% boric acid solution which had been adjusted to
pH=lO.O with KOH. Teflon tubing (0.5 millimeters i.d.) was used with the
post column apparatus and the post column reactor was 3 meters long.
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C. PREPARATION OF DERIVATIZED CD BONDED PHASE

~-Cyclodextrin

was attached to 5 ll spherical silica as previously

reported (96). Four grams of the

~-CD

bonded phase were dried

overnight under vacuum in a drying gun using MeOH and P205. The
dried sorbent was placed in a 3-necked round bottom flask. Anhydrous
solvent (Aldrich) (100 mL) was added. Pyridine was used as the solvent
for the isocyanate derivatized phases and toluene (+ 3 mL pyridine) was
used for the acid chloride derivatized phase. The mixture was refluxed
until all the water was removed (as an azeotrope into a Dean-Stark trap).
The derivatizing agent was added (neat) and the mixture was refluxed for
about four hours (three hours for the acid chloride derivatized phase). The
isocyanate derivatized ~-CD bonded phases were collected on a fritted glass
filter and washed with approximately 100 mL of pyridine followed by 200
mL of MeOH and then air dried. The acid chloride derivatized

~-CD

phase was also collected on a fritted glass filter and washed with
approximately 100 mL each of pyridine and MeOH, about 10 mL of H20
followed by MeOH and then air dried.
The bonded sorbents were submitted for carbon analysis. The surface
concentration was calculated according to the equation (97).

(Jlmoles/m2)

=

%C x 106

S[1200Nc- %C(M- 1)]

where Nc is the number of carbons in the ligand, M is the molecular
weight of the ligand and S is the surface area of the substrate, which,
according to the manufacturer, is 170 m2fg. For ~-CD (Nc = 42, M =

45

1135), the coverage was calculated to be 0.20 J.Lmoles/m2. To determine
the degree of substitution on the

~-CD

of the derivatized

~-CD

phases, the

%C from the CD+ linkage chain was subtracted from the total %C and
M - 1 was substituted by M in the denominator. The degree of substitution
for each of the phases were calculated and are reported in Table I. The
sorbents were all packed into 250 x 4.6 mm stainless steel columns.
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D. SAMPLE PREPARATION
1. Urinalysis

All samples were dissolved in the mobile phase solution immediately
prior to analysis. The results of this study were reproducible if the column
and the detector current were allowed to stabilize before beginning the
analysis. The average concentration of the L-amino acids was 10 mM.
Despite the large amount of sample injected, it was still possible to attain
baseline resolution with a single column. When using fluorescence
detection the average concentration of the L-amino acid standard solution
was 0.2 mM.
Urine samples were collected from young healthy adults. The mobile
phase solution and the urine samples were filtered with 0.2 Jl filters. If the
urine appeared cloudy, the sample was centrifuged at 1550 rpm for 5
minutes. The supernatant was filtered and analyzed. All remaining urine
samples were refrigerated at 4 °C.
In one set of experiments the samples were concentrated by freeze
drying. The freeze-dried samples were dissolved in the mobile phase
solution immediately prior to analysis.

2. Blood serum analysis

Venous blood was collected from young healthy adults. The blood
samples were placed in a refrigerator for twenty-four hours to allow
coagulation. The samples were centrifuged at 1550 rpm for fifteen
minutes. The supematent was collected and filtered with a 0.2Jl filter.
Solid phase extraction (SPE) was performed to remove proteins. A C18
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SPE cartidge was utilized. The cartridge was washed with 2 x 2 milliliters
(mL) of MeOH and H20, respectively. Two to three mL of sample was

introduced onto the cartridge. The sample was eluted using one mL of
aqueous perchloric acid (pH=2.0). Thi_s sample was immediately analyzed
using a coupled column system.
In one set of experiments the samples were concentrated by freeze

drying. The freeze-dried samples were dissolved in the mobile phase
solution immediately prior to analysis.

3. Amniotic fluid analysis
Frozen amniotic fluid samples were graciously donated by Dr. Sau W.
Cheung, Ph. D at Washington University School of Medicine. These
samples were collected from pregnant women and stored in a freezer at 40
C until analysis. The age of the samples ranged from several days to
several years .
The amniotic fluid samples were thawed for five to ten minutes at
room temperature. The samples were filtered with a 0.2J.l filter and
analyzed using a coupled column system.
In one set of experiments the samples were concentrated by freeze

drying. The freeze-dried samples were dissolved in the mobile phase
solution immediately prior to analysis.
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IV. RESULTS AND DISCUSSION
A. CHIRAL COUNTER IONS IN NORMAL PHASE TLC

A method was developed for the thin layer chromatographic (TLC)
separation of enantiomers and diastereomers involving the use of chiral ion
interaction agents based on prior normal-phase HPLC studies (26-28).
Several aromatic amino alcohols were resolved by TLC on diol and/or high
performance silica gel plates using a mobile phase containing (lR)-(-)ammonium-! 0-camphorsulfonate (CSA) or N-carbobenzoxy-glycyl-Lproline (ZGP). Results which were attained using ZGP or CSA as chiral
mobile phase additives in TLC are similar to those obtained using the same
CMAs in HPLC. One major difference was that separations of aromatic
amino alcohols in HPLC involved the (+) antipode of 10-camphorsulfonate
whereas the same work performed in TLC used the (-) antipode. The
chiral separation mechanism for each chromatographic method (HPLC and
TLC) was the formation of diastereomeric ion-pairs.
For the TLC studies as well as the HPLC studies, no enantiomeric
separations could be achieved with any of the ion interaction agents unless
the solvents and the chromatographic bed were thoroughly dried.
Presumably, this was because an intimate, multi-point interaction must
occur between the chiral ion interaction agent and the racemic substrate.
Hydrogen bonding is particularly important when these associations occur
(7t-7t

interactions, dipole-dipole interactions and steric interactions are also

pertinent). If too much water is present, the water may preferentially
associate via hydrogen bonding with the chiral selector and/or racemate

thereby negating interactions between these species that are important for
chiral recognition.
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Dichloromethane was the major component of the mobile phase.
However, it was difficult to dissolve ammonium camphorsulfonate (CSA)
in dry dichloromethane. Several organic co-solvents were tested to
evaluate their ability to solubilize CSA. These solvents included: 1pentanol, 1-butanol, 2-propanol, ethanol, methanol, acetonitrile, and
ethylene glycol. CSA was most soluble if ethylene glycol was used but the
solution appeared to form two layers and thus was impractical. CSA was
soluble in solutions which contained the lower molecular weight alcohols.
As was expected, the higher the percent of alcohol in the mobile phase, the
greater the solubility of the chiral ion interaction agent. It was possible to
attain resolution of metoprolol at 95/5 (v/v) dichloromethane/methanol
although CSA displayed limited solubility in mobile phases which contained
less than 10% alcohol by volume. The best results were obtained when dry
methanol or 2-propanol were present in the mobile phase.
No solubility problem was encountered with these mixed mobile
phases when using ZG P as a chiral mobile phase additive, so it was possible
to study the effects of different CMA concentrations. In this study, the
concentration of ZGP was varied from 6.5-16.8 mM without any
significant change in the retention factor (Rf) or the separation factor (a)
(Table 1). The capacity factors (k') for the enantiomers usually decrease
with an increase in the concentration of the counter ion. This is probably
due to increased competition between the counter ion and the
diastereomeric ion-pair for adsorption sites on the stationary phase.
Separations obtained on silica gel (K5F) and high performance silica
gel (HP-KF) gave approximately the same Rf values but the K5F did not

50

Table I. Effect of Varying Concentration of ZGP
on Enantioselectiv ity for Propranolol in TLC Study
Concentration of

a

ZGP (mM)

6.5

0.07

0.23

1.7

6.8

0.07

0.14

1.9

13.6

0.06

0.21

1.8

16.8

0.08

0.20

1.6

*Experimental conditions: The mobile phase consisted of 90/10, methylene
chloride/methanol. The stationary phase was HP-KF silica gel. The
method of detection was a Schimadzu dual wavelength TLC scanner (CS910).
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offer the same selectivity as HP-KF. Separations on the ethyl (KC2F)
plates gave higher Rf values than the HP-KF plates but no enantiomers
were resolved on the KC2F plates. The ethyl and diol plates gave similar
Rf values except there was much greater streaking on the ethyl plates.
There was very little spot movement on either the aluminum oxide plates
or the cellulosic plates. The only TLC plates on which effective,
reproducible enantiomeric separations could be obtained were the diol and
the high perfonnance silica gel plates (HP-KF).
The structures of the resolved compounds as well as pertinent separation
data are given in Table II. Note that all of the compounds have three
functionalities in common: an aromatic ring, an a-hydroxyl group and a
~-amine.

Table II shows that it was possible to achieve very efficient

separations with the use of CSA and ZGP as chiral mobile phase additives
(CMAs). Several compounds were separated with both CMAs. In four out
of five of these compounds (Table II) a higher selectivity was obtained by
adding 5 mM triethylamine (TEA) when ZGP was the CMA. A majority
of the racemates were resolved on the HP-KF plates. Retention on the
stationary phases was due to the OH-groups present on both the HP silica
gel and the diol plates. These types of plates displayed a certain similarity
in their chromatographic behavior, however the silica gel plates were more
strongly adsorbing than the diol plates (98). Note that the mobile phase
which was used in conjunction with the diol plates had a lower percentage
of alcohol and used a less polar alcohol in comparison with the mobile
phases used with the HP silica gel plates. There were two similarities
among the compounds resolved with the diol plates: none of these
compounds contained a primary amine and each racemate had a terminal
branched hydrocarbon group. The separations achieved on the diol plates
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Table IT. Compounds Separated Using ZGP or CSA as
Chiral Mobile Phase Additives
Enantiomers

Rn

Rf2

a

Conditions

Octopamine

0.15

0.33

2.2

7.9mMCSAa

0.07

0.12

1.7

6.7mMZGPb

0.05

0.26

5.2

5.9mM zapa

0.03

0.14

4.7

6.8mMCSAC

0.08

0.20

2.5

6.7 mM ZGPC

0.05

0.20

4.0

9.3 mM CSAC

0.14

0.38

2.7

5.9 mM zapa

0.12

0.30

2.5

6.8 mM CSAa

HOCHOi1NH,

$
OH

Pindolol
N

~

OCHP,IOi1NHOi(Oi,lt
I
OH

Norphenylephrine
OIOi~

~6..
OH

Propranolol

Isoproterenol
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Metoprolol
OI,OCHtOit

0.11

0.17

1.5

10.7mMCSAb

0.26

0.51

2.0

5.8mMZGPa

0.39

0.55

1.4

13.9mMCSAb

0.01

0.05

5.0

6.7 mM ZGPb

0.05

2.5

9.3 mM CSAb

0.15

0.32

2.1

6.8mMCSAC

0.06

0.26

4.3

6.9mMZGPa

-@-OCHt~:NHCH(OiJh

Timolol
,s,

N N

,-...JUl.

0~

OO!t<fHO!tNHC(Oi,),
OK

Diastereomers
Labetalol

Methoxamine
c~
I

HOCHCHNH2
OOCH]
H 3 CO

Pheny!propanolanune
HOOIO!Ol3

@NH,

a HP Silica gel plates with 75/25 (v/v) methylene chloride/methanol
b DIOL plates with 95/5 (v/v) methylene chloride/2-propanol
c HP Silica gel plates with 90/10 (v/v) methylene chloride/methanol

NOTE: All separations achieved with ZGP contained 5 mM TEA.
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gave lower a values than those attained with the HP-KF plates. None of
the adrenergic compounds were resolved on the dial plates. Separations
were optimized for most of the adrenergic compounds by using a higher
alcohol content in the mobile phase whereas most of the separations for the
~-adrenergic blockers were optimized with a lower percentage alcohol

content and/or a less polar alcohol in the mobile phase.
Figure 13 shows two TLC chromatograms. These chromatograms
illustrate the high degree of stereoselectivity obtainable with this method.
Both chromatograms were developed on HP-KF plates using 75:25 (v/v)
dichloromethane/methanol but each used a different CMA. The plate on
the left illustrates the separation of isoproterenol and propranolol using
CSA as a chiral ion interaction· agent. The plate on the rightt shows the
resolution of methoxamine, norphenylephrine, phenylpropranolamine and
octopamine employing ZGP and triethylamine (TEA). Methoxamine and
phenylpropranolamine have two stereogenic centers so there are four
stereoisomers for each compound. The number of stereoisomers is
determined by application of the 2n rule were n = the number of
stereogenic centers for the compound.

The TLC densitometric scans for

the above-mentioned plate showed three peaks for methoxamine and two
peaks for phenylpropranolamine. The resolution of methoxamine was not
reported under these conditions because it was not possible to determine
which stereoisomers were resolved. The separation of
phenylpropanolamine was presumed to be between diastereomers rather
than between enantiomers.
Figures 14 and 15 show three TLC densitometric profiles of TLC
plates scanned at 254 nm, 275 nm and 300 run, respectively. Notice that
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CA)

(B)

B.!
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I

isopr

propra

methox

.···.·~

Lo;:..

no'rph '
o~tap
ph-pro

Figure 13: Thin layer chromatogram s on 5 x 5 em HPTLC silica gel. (A)
Mobile phase 75:25 CH2Cl2: MeOH containing 6.8 mM camphorsulfonic
acid (CSA). isopr (isoproterenol); propra (propranolol). (B) Mobile
phase 75:25 CH2Cl2: MeOH containing 6.9 mM N-carbobenzoxy-glycyl-Lproline (ZGP) and 5 mM triethylamine. methox (methoxamine ); norph
(norphenyleph rine); ph-pro (phenylpropan olamine); octop (octapamine).
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Figure 14: TLC densitom etric scans (using a Shimadz u CS-910 at three
different waveleng ths) showing the resolution of racemic
norpheny lephrine. The stationary phase was a HPTLC silica gel plate (5x5
em). The mobile phase consisted of 6.6 mM N-CBZ-g ly-L-pro line + 5
mM triethylamine dissolved in 75:25 (v/v) CH2CI2: MeOH.
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Figure 15: TLC densitom etric scans (using a Shimadz u CS-910 scanner)
showing the resolutio n of racemic isoproterenol (a bronchod ilator). The
stationary phase was a HPTLC silica gel plate (5x5 em). The mobile phase
consisted of 6.8 mM camphor sulfonic acid dissolved in 75:25 (v/v)

CH2CI2: MeOH.
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the peak areas maintain the same relative proportions at different
wavelengths thereby making it possible that these were enantiomeric
separations. The stationary phase was HP silica gel and the mobile phase
was 75:25 (v/v) dichloromethane/methanol for both separations. In Figure
14, norphenylephrine was resolved using ZGP and TEA. Figure 15
illustrates the resolution of racemic isoproterenol; the chiral ion
interaction agent was CSA.
A comparison was made between various N-CBZ-amino acid
derivatives as CMAs: N-CBZ-alanyl-L-proline (ZAP), N-CBZ-isoleucylL-proline (ZIP), N-CBZ-L-proline (ZP) and N-CBZ-glycyl-L-proline
(ZG P). Table III shows that it was possible to attain some separations with
all of the N -CBZ-amino acid derivatives. However, ZGP separated the
largest number of compounds and gave higher a values than the other NCBZ-amino acid derivatives. Note that the only compound resolved using
diol plates and 2- propanol with an N -CBZ derivative was metoprolol.
Also, metoprolol was the only compound resolved using ZAP or ZP as a
CMA. It was possible to separate two adrenergic compounds and one~
adrenergic blocker using ZIP as a CMA (Table III). From these results it
was clear that ZGP was the best chiral ion interaction agent of the N-CBZamino acid derivatives in resolving the racemates of interest in this study.
In thin layer chromatography, ZGP and CSA demonstrated unique
abilities in separating enantiomeric amino alcohols. Of the ten pairs of
enantiomers resolved in this TLC study; two compounds could only be
separated using ZGP, three compounds could only be resolved using CSA
and five of the compounds analyzed could be separated using either CMA.

Of the enantiomers which could be resolved with either CMA, a higher
stereoselectivity was obtained in four out of five of these compounds
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Table III. Compounds Separated Using Other NCBZ Amino Acid Derivatives as CMAs.
Compounds

Rn

Rf2

a

Conditions

N orphen y lephrine

0.20

0.48

2.4

7.5 mM ZIPa

Octopamine

0.20

0.52

2.6

7.5 mM ZIPa

Metoprolol

0.17

0.28

1.6

6.9 mM ZIPb

0.17

0.28

1.6

7.0 mM ZAPb

0.17

0.28

1.6

7.8 mM zpb

Propranolol

0.10

0.30

3.0

6.3 mM ZGPa

Isoproterenol

0.04

0.10

2.5

6.3 mM ZGPa

Phenylpropanolamine 0.08

0.32

4.0

6.3 mM ZGPa

0.20

0.40

2.0

5.8 mM ZGPa

Timolol

aHP Silica Gel Plates with 75/25 CH2Cl2/MeOH
boiol plates with 95/5 CH2Cl2f2-propanol
ZP: N-CBZ-L-proline
ZIP: N-CBZ-isoleucyl-L-proline
ZAP: N-CBZ-alanyl-L-proline
ZGP:N-CBZ-glycyl-L-proline
NOTE: The TEA was not used as an additive for these separations.
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(Table II) when ZGP was the CMA. It was possible to obtain better
stereoselectivity in HPLC with ZGP than with CSA for the amino alcohols
analyzed (99). In HPLC, the preferred stationary phase was the DIOL. In
TLC, the largest number of compounds were separated with the high
perfonnance silica gel plates although it was necessary to use the DIOL
plates to resolve some of the analytes. The only compound which could be
separated on either type of TLC plate was timolol.
There were several mobile phase dissimilarities which could be noted
in a comparison between HPLC and TLC when ZGP and CSA are used as
CMAs. The addition of triethylamine (TEA) to the mobile phase in HPLC
decreased retention times but did not effect stereoselectivity. The use of
TEA in the mobile phase in TLC gave different results with different
compounds (Table IV) and no general trend was noted. Acetonitrile,
tetrahydrofuran, 1-pentanol and ethyl acetate could be used as polar
modifiers in HPLC but 1-pentanol was the only modifier which did not
contribute to peak asymmetry. Solute movement in TLC was restricted to
mobile phases which contained an alcohol as co-solvent. The Rf values in
TLC increased with an increase in the amount of alcohol in the mobile
phase. This is expected because the solutes travel farther on the plate if
interactions with the mobile phase are enhanced. Conversely, an increase
in the alcohol content resulted in decreased retention times in HPLC. If
mobile phase interactions are enhanced in HPLC, the solute elutes from the
column faster. The a values changed, in TLC, if the amount of alcohol in
the mobile phase was varied.
This approach was highly successful in separating chiral aromatic
amino alcohols. Once the separation was optimized, it was possible to
attain enantiomeric separations with good a values in approximately 30

6I

Table IV. The Effect on Enantioselectivity when
TEA is added to Mobile Phases Containing ZGP in
TLC Studies

Compound

with TEA

Rf1

Rf2

without TEA

a

a

Isoproterenol

0.14 0.38

2.7

0.04 0.10

2.5

Phenylpropranol-

0.06 0.26

4.3

0.08 0.32

4.0

0.26 0.51

2.0

0.20 0.40

2.0

Norphenylephrine 0.05 0.26

5.2

0.05 0.26

5.2

0.08 0.20

2.5

0.10 0.30

3.0

am me

Timolol

Propranolol

*Experimental conditions: The mobile phase consisted of 75/25, methylene
chloride/methanol. The stationary phase was HP-KF silica gel. A
Schimadzu dual wavelength TLC scanner(CS-910) was used for detection.
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minutes. This appeared to be a good method for screening specific types of
racemic compounds and different solvent systems for HPLC in a relatively
short time. Many of these chiral ion interaction agents were relatively
inexpensive and provided an easily accessible pathway for enantiomeric
separations, but the supply of CSPs for TLC remains limited.
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B. CHIRAL MOBILE PHASE ADDITIVES IN REVERSE PHASE TLC

Recent investigations into the use of COs as chiral separation agents
involved the utilization of different types of cyclodextrin derivatives as
CMA in reverse-phase media. Derivatization of some of the CD hydroxyls
resulted in enhanced aqueous solubility relative to the native CD (32).
Similar mobile phases were used for the native and derivatized
cyclodextrins. Some compounds, such as dansyl amino acids, could be
separated using either the native or the derivatized CD.
For the

maltosyl-~-CD

study, three types of reversed-phase TLC

plates were used: octadecyl, diphenyl, and ethyl. Table V contains data
and conditions for compounds separated using maltosyl-~-CD as a CMA.
Separations were achieved for the dansyl amino acids on all three types of
plates. The best separation for dansyl leucine was obtained using the
octadecyl plates whereas the best results for dansyl valine were obtained
with the ethyl plates. The separation factors (a) obtained with the dansyl
amino acids showed little variance between the plate types indicating that
the plates affected efficiency more than selectivity. It was possible to
separate the diastereomers, quinine and quinidine, with all plate types as
well. The separation factor (a) was the same for the ethyl and diphenyl
plates but the a value achieved with the octadecyl plates was much lower.
The preferred TLC plate was the ethyl (KC2F) because a greater number
of compounds were separated using this plate type. Note that in all cases
the mobile phase consisted of an acetonitrile-water mixture with a
derivatized

with

~-cyclodextrin

as the CMA. The best results were obtained

30no (v/v) acetonitrile-water mixtures and 0.4 M maltosyl-~-CD.
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Table V. Compounds Separated Using Maltosyl
Cyclodextrin as CMA

~

Reversed
Phase
Enantiomers

Rn

Rf2

!!

Plate Type

(1) DL-Alanine-~-naphthylamide

0.71

0.66

1.08

ethyl

(2) Dansyl DL-leucine

0.22

0.16

1.38

octadecyl

(3) Dansyl DL-valine

0.40

0.31

1.29

diphenyl

0.39

0.34

1.15

ethyl

(5) N'-(2-N aphthylmethyl)nomicotine 0.50

0.30

1.67

ethyl

(4)

DL-Methionine-~-naphthylamide

Diastereomers
(1) Cinchonidine/Cinchonine

0.23

0.12

1.92

ethyl

(2) Quinidine/Quinine

0.09

0.03

3.00

ethyl*

*Analysis using diphenyl plate produced the same value for selectivity (a).
The mobile phase consists of: 30/70, acetonitrile/water which contains
0.4 M maltosyl-~-CD and 0.6 M NaCl.
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When greater than 30% acetonitrile was added, some streaking occurred
and most of the solutes traveled with the solvent front. There was more
streaking and no separations were achieved when methanol was used as an
organic modifier. The minimum concentration of maltosyl-(3-CD required
for a chiral separation was 0.4 M.
The retention behavior of the the amino acid derivatives was the same
as observed in prior studies (30). In Figure 16, the D enantiomer elutes
ahead of the L enantiomer because the chiral agent is in the mobile phase.
A reversal of the retention behavior is seen if the chiral agent is bonded to
the stationary phase exclusively.
All of the compounds in Table V contain a naphthyl group or two
fused aromatic rings. The size of the internal diameter of (3-CD is
approximately the size of a naphthyl moiety. There is a relatively "tight
fit" for molecules with two or more rings which are complexed by (3-CD
(41). It is believed that chiral recognition is enhanced if the conformation
and movement of the complexed solute is restricted inside the CD cavity
( 100). The largest separation factors indicated in Table V were for
compounds which had the chiral center located between two aromatic ring
systems, e.g.-N'-(2-naphthylmethyl)nomicotine, quinidine/quinine and
cinchonidine/cinchonine. This was in agreement with prior work which
indicated that enantioselectivity was enhanced when a chiral center was
"sandwiched" between two 1t systems (101). This enhancement was
believed to be due to the rigidity of the chiral molecule and the fact that the
chiral center appeared to be the main point at which rotation can occur
between the two 1t systems. In addition, diastereomers have different
chemical properties and one would expect to see larger separation values
for the cinchona alkaloids.
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Figure 16. Reversed phase TLC chromatograms showing the separation of
enantiomers (A) dansyl D,L-valine; dansyl D,L leucine; D,L-alanine-f3naphthylamide and racemic N'-(2-naphthylmethyl)nomicotine.
Chromatogram (B) shows a typical separation of the indicated diastereomers.
The mobile phase consists of:

3ono acetonitrile/water which contains 0.4 M

maltosyl-f3-CD and 0.6 M NaCl.
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No separations were obtained using dimethyl-P-CD as a CMA. The
range of CMA concentration was 0.4- 1 x 10-3 M. The organic modifier
used was acetonitrile. Due to the scarcity of available planar
chromatographic techniques for resolving enantiomers, the use of
substituted COs as CMAs in reverse-phase media remains a viable
alternative to CSPs.
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C. TLC STUDY OF THE EFFECT OF THE DEGREE OF
SUBSTITUTION OF HYDROXYPROPYL-~-CYCLODEXTRIN

Several derivatized amino acids were separated by thin layer
chromatography (TLC) utilizing hydroxypropyl-f3-cyclodextrin (HP-f3CD). Studies were conducted to determine the effect that the degree of
substitution of HP-f3-CD would have on: the resolving abilities of the
CMA, the time of development and the viscosity of the hydroxypropyl-f3CD mobile phase solutions. Unfortunately, maltosyl derivatized f3-CD
having different degrees of substitution was unavailable.
Table VI contains viscosity data (in centiposes) and development times
(in hours) for the HP-f3-CD solutions which were used in this study. Two
mobile phase compositions were used in this study. As seen in Table VI,
the viscosity of the solutions increased and the % plate traversed decreased
as the number of substitutents per CD molecule increased. The % plate
traversed indicated how far the solvent front traveled during development
relative to the length of the plate. The experiment (i.e., plate development)
was stopped when the solvent front ceased movement. The % plate
traversed increased and the development time decreased if the top of the
development chamber was covered in parafilm rather than a small glass
beaker. The parafilm formed a better seal on the container thereby
preventing the loss of vapor.
Table VII contains separation data for several enantiomeric and
diastereomeric compounds. Figures 17 and 18 show the separation of
stereoisomers using hydroxypropyl-f3-cyclodextrin supplied by Wacker and
Phannatec, respectively. It was important to note that the best separations
for all of the analytes were obtained using the CMA with the lowest
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Table VI.

Viscosity Data (f.!) and Development Times (T d) for

Hydroxypropyi-~-CD

CD Derivative
OS = 2

Derivatives Study

bl1 (cp)

T d 1(hrs) % plate developed

28.5

48

98

7

35.7

40

95

9

64.6

45

75

MS =0.6

33.8

40

75

0.9

62.8

45

41

!!2(Cp)

T d2(hrs) % plate developed

DS=2

8.2

17

88

7

14.2

16

84

9

17.8

17

66

MS =0.6

11.0

25

84

0.9

16.3

27
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f.ll and T d 1 are values obtained using solution 1. The mobile phase in
solution 1 consisted of: 30/70 (v/v) acetonitrile/water which contained 0.4
M HP-~-CD and 0.6 M NaCI.
f.l2 and T d2 are values for solution 2. The mobile phase in solution 2
consists of: 35/65 (v/v) acetonitrile/water which contained 0.3 M HP- ~-CD
and 0.6 M NaCI.
The top of the TLC development chamber was covered in parafilm.
Pharmatec indicated the degree of substitution (DS) of the CD
mole cule and Wacke r indicate d the molar substitution (MS) of their
product.
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Figure 17. Reversed-phase TLC chromatograms showing the separation of
enantiomers (A) and (B) dansyl DL-leucine; dansyl DL-methionine; dansyl
DL-norleucine; dansyl DL-phenylalanine and dansyl DL-valine. The mobile
phase consists of: 30no acetonitrile/water which contains 0.4 M HP-P-CD
(Wacker) and 0.6 M NaCI. The stationary phase was octadecylsilane.
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Figure 18. Reversed-phase TLC chromatograms showing the separation of
enantiomers and diastereomers(A),(B), and (C) cinchonine/cinchonidine;
methionine-(3-naphthylamide; 5-(4-methylphenyl)-5-phenylhydantoin and
quinine/quinidine. The conditions for each chromatogram was the same
except the degree of substitution of the CMA. The mobile phase consists of:
35/65 acetonitrile/water which contains 0.3 M HP-(3-CD (Phannatec) and
0.6 M NaCl. The stationary phase was octadecylsilane.

72

number of substitutents. The general trend was that the separation factor
(a) decreased as the degree of substitution (or the molar substitution)

increased. This held true for all enantiomeric separations. The only
exceptions noted were with the diastereomeric separations where the a
value was larger if the OS of the CMA was nine rather than seven. Since
diastereomers have different chemical properties, this different behavior
may be due to factors other than the enantioselective properties of the
CMA.
The changes in chiral selectivity between the native and the derivatized
CD may be due to the loss of hydrogen bonding groups alpha to the chiral
centers of the CD molecule and/or the gain of additional interaction sites
about the mouth and the base of the derivatized CD cavity. If there was a
small number of substituents on the cyclodextrin ring, it appeared that
these substituents offered additional interaction sites for the analyte without
prohibiting the formation of an inclusion complex. A large number of
substituents about the mouth and base of the CD cavity may interfere with
the fonnation of an inclusion complex, which is thought to be important
for chiral recognition.
This study indicated that the degree of substitution on functionalized
COs was an important factor which may affect the chiral separation
mechanism. The aqueous solubility of hydroxypropyl J3-CD appeared to
increase as the degree of substitution increased. Increases in solubility
allowed larger concentrations of the CMA which may lead to enhanced
enantioselectivity. Therefore, in using derivatized COs as CMAs, it
appeared that there was a tradeoff between the enhancement of the
solubility of the CMA in aqueous media and the stereoselectivity of the
derivatized CD. The degree of CD substitution should be high enough to
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Table VII. Compounds Separated Using
Hydroxypropyl-~-CD Derivatives as CMAs in RPTLC
OS

a

MS

a

2

1.26

0.6

1.22

7

1.16

0.9

1.17

9

1.09

Dansyl DL-methionine 2

1.15

0.6

1.10

7

1.04

0.9

2

1.21

0.6

1.19

7

1.10

0.9

1.08

9

1.06

2

1.15

0.6

1.10

7

1.06

0.9

1.07

0.6

Enantiomers

Dansyl DL-leucine

9

Dansyl DL-norleucine

Dansyl DL-phenylalanine

9

Dansyl DL-valine

2

7
9

0.9

1.05
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DL-Methionine-P-

2

1.20

0.6

1.10

naphthylamide

7

1.12

0.9

1.12

9

1.10

(RS)-5-( 4-methyl-

2

1.10

0.6

1.10

phenyl)-5-phenyl-

7

1.09

0.9

1.08

hydantoin

9

1.10

2

1.90

0.6

1.90

7

1.40

0.9

1.40

9

1.50

2

1.50

0.6

1.70

7

1.27

0.9

1.35

9

1.30

Diastereomers

Quinine/Quinidine

Cinchonine/Cinchonidine
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increase the solubility to approximately 0.3-0.4 M, however the
cyclodextrin should not be exhaustively derivatized since this appears to
inhibit the formation of an inclusion complex and reduce the
enantioselectivity for many racemates. A delicate balance must be attained
so that the degree of derivatization is adequate to increase the selectivity
and solubility of the CMA but not large enough to obstruct the formation
of an inclusion complex or to unnecessarily lengthen development times.
The development times were longer for the derivatized CD than for the
native CD (in saturated urea solution) because a greater concentration of
CMA was used and the viscosity of the solution correspondingly increased.
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D. NATIVE 1)-CYCLODEXTRIN IN REVERSE PHASE HPLC
The majority of reports of CD-CMA were performed in TLC whereas
most applications of CD-CSP were in HPLC and gas chromatography
(GC). Cyclodextrin bonded silica gel can be used as a CSP in LC to
resolve racemic mixtures of pharmaceutical compounds. The enantiomers
of 25 different racemic drugs were resolved on CD-CSPs in the reversephase mode and studies were conducted regarding the chiral recognition
mechanism applicable in these separations.
Table VIII lists the names, formulae and chromatographic conditions
of the racemic drugs whose enantiomers were separated using native CObonded CSPs. The k' values listed correspond to the first eluting
enantiomer; a is the ratio of the first eluting k' value to the last eluting k'
value, and Rs is the resolution factor.
All separated drugs, except norgestrel, contain at least one aromatic
ring. As shown previously (41, 95, 102), the internal
cyclodextrin

(~-CD)

toroidal~

cavity has a diameter varying from 0.6 nm at the

bottom to 0.8 nm at the top of the cavity and is relatively non-polar. It
could easily accommodate molecules or parts of molecules having the size
of a five, six, or seven-atom aromatic ring. The secondary 2- and 3hydroxyl groups of each glucopyranoside ring stand axially at the mouth of
the CD cavity, forming a polar crown that is most important for chiral
recognition.
It was thought that there should be a difference in chiral CD
recognition between compounds with the chiral center in an acyclic portion
of the molecule (1 0 1). While this seemed to be a factor, it also appeared
that the hybridization of the groups attached to the chiral center
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Table VIII. Chromatographic Parameters of the
Separation of Enantiomeric Drugs
Therapeutic category &
drug name

Formula

a

Rs

MeCH-Buffera 8.04
70 - 30

1.1

0.7

MeOH-Buffera 7.67
27-73

1.06

1.2

g,h

MeOH-Buffera 9.39
15-85

1.14

1.5

g

MeOH-Buffera 14.8
20-80

1.14

1.6

g

MeOH-Buffera 0.48
40-60

1.33

1.8

b

MeCN-Buffera 1.97
10-90

1.15

1.5

g

MeCN-B ufferb 2.7
10-90

1.46

0.9

MeCN-Wate~

1.70

1.1

Mobile phase
%v/v

k'

rem.

Anti-inflammatory agent

Ibuprofen
(ai3)zCH-CH2

Ketoprofen

~3

-COOH

CH3

0

~&-cooH

Sedative, anticonvulsivant
N
~,rn3
)=o'

Hexobarbital

CH3·CH

N

cj;_r3:ra

Mephobarbital

Me phenytoin

0

Oi3

rn3-~N'
NAO

cr

0

Phensuximide

ai3
I

0~
H

Etomidate

~N-cH(CH3)-@

No::::(

COOH

5-95

1.8
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{3-adrenergic blocker
1.04

1.4

g,h

MeOH-Buffer'l 3.51
32-68

1.03

0.9

g,h

0.48

1.24

1.1

1

MeCN-Buffer'l 5.86
15- 85

1.07

1.5

g

MeCN-Buffera 2.94
15-85

1.03

0.7

g,i

MeOH-Buffer'l 0.50
30-70

1.44

1.9

g

MeOH-Buffera 2. 78

Propranolol

~·Ol2-CHOH·CH2·NH-Ol(Ol3)2 25-75

Metoprolol

CH~r0i2-o- O-CHr-OiOH-Oiz·NH.ai(CHl):
Progestrin

ff=

Norgestrel

MeCN-Water
30-70

Antihistamine
Chlorpheniramine
Qi...CH.....'If(c:Hyz

d-~Va
Vasodilatator
Verapamil
.

CHrQ

0-01,

Ol(c:Hyz

CH,..0-0-

~-<CH-..hj'lf-<OfVt-{j- 0-01,

CN

01,

Diuretic
Chlonhalidone

o:}.Q-a
SOr-"lH~
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Anticorticosteroid
1.03

0.9

g,J

1.14

1.6

g,h

1.05

0.8

1.04

0.8

5.74

1.19

1.3

R = isopropenyl

MeOH-Buffere 3.20

1.30

2.3

R =phenyl

MeOH-Buffere 6.12

1.19

1.3

R = methoxy

MeOH-Buffere 1.21

1.40

2.5

R =ethoxy

MeOH-Buffer'l 1.62

1.40

2.5

MeCN-Buffer'l 7.49

Arninoglutethimide

15-85

Central nervous system stimulant
MeCN-Buffer'l 1.17

Methylphenidate

10-90

H
I

Huperzine A

~

MeCN-Bufferf 1.83

10-90

1%

Narcotic, analgesic
Methadone

0
. 6

ail

CH,..c:H~.cHrCH-NCai,)t

MeCN-Buffer'l 2.38

15- 85

Compounds under pharmacological investigation
Idazoxan derivatives
R =ethyl

CQ!o

Buffer<!

H

10-90

10-90

10-90

10-90

g,J

80

Fluoxetine

SQ 30840

2.55

1.2

1.1

MeOH-Buffera 5.02
40-60

1.1

0.7

MeCN-Buffe~

1.39

3.7

MeOH-Buffe~

Efaroxan

5-95

6 .

CP -o-Q.Oi~'m-CH!
3

cfl5'"

2.33

20-80

N~

Column 25 em x 4.6 mm i.d. Cyclobond I (~-cyclodextrin). Mobile phase composition
indicated, MeOH = methanol, MeCN = acetonitrile, flow rate 1 mL/min. Room
temperature.
a) 1% (w/v) triethylammonium acetate in water (TEAA), pH 4.1.
b) 5% (w/v) triethylammonium acetate in water (TEAA), pH 7.
c) 0.01% (w/v) diethylamine in water.
d) 1% (w/v) triethylammonium acetate in water (TEAA), pH 5.98.
e) 1% (w/v) triethylammonium acetate in water (TEAA), pH 4.2.
f) 1% (w/v) triethylammonium acetate in water (TEAA), pH 7.
g) Adapted from ref. [13].
h) Two 25 em Cyclobond I columns were used in series.
i) A Cyclobond II column was used (y-cyclodextrin).
j) A gradient from 10% MeCN to 20% MeCN in 20 min. was used; mean composition
MeCN 15% v/v.
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have a significant effect. The highest resolution factor was obtained for
compound s (i) whose chiral center was part of a ring and (ii) whose chiral
center was linked to at least two sp2 hybridized carbon atoms (101). The
highest resolution factor, Rs = 3.7 was obtained for compound SQ 30840
whose chiral center was part of a ring and is linked to three sp2 hybridized
carbon atoms. The lowest resolution factor, Rs = 0.7, was obtained for
flouxetine whose chiral center is not part of a ring and is linked to only one
sp2 hybridized carbon atom.
The effects of substituents were demonstrated with the Idazoxan
derivatives . Figure 19 shows the chromatogram of the methoxy,
isopropeny l, and phenyl Idazoxan derivatives. The resolution was maximal
with the two ether substituents (methoxy and ethoxy, Rs = 2.5) and with the
isopropeny l substituent (sp2 hybridized carbon atom, Rs = 2.3). The
phenyl substituent, also contains a sp2 hybridized carbon atom; however, it
produced a slightly lower resolution factor (Rs = 1.3; Table VIII). In this
case, steric effects must be taken into account and it is likely that the bulky
phenyl groups interfered somewhat with chiral recognition thereby
negating the advantage of having an additional sp2 hybridized carbon
linked to the chiral center.
The comparison of mephobarbital and mephenytoin was interesting:
these two compounds are structurally identical, but the carbonyl group
attached to the chiral center of mephobarbital was missing in mephenytoin.
Although the CD chiral recognition of the two compounds was similar
(Rs= 1.6 and 1.8, a= 1.14 and 1.33, respectively); the small carbonyl
structural change made a tremendous difference in the global retention of
the two molecules (k' = 14.8 and 0.48, respectively). It must be noted
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Figure 19. Separation of Idazoxan derivatives. Column P-cyclodextrin 250
x 4.6 mm i.d.; mobile phase: 95% buffer (1% TEAA w/v, pH=4.2)/ 5%
acetonitrile v/v, 1.5 ml/min; detection: UV 270 nm, 0.01 a.u.f.s. 1,2:
methoxy derivatives, 3,4: isopropenyl derivatives, 5,6: phenyl derivatives
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Figure 20. Separation of D and L norgestrel on a 25 em y-cyclodextrin
column; mobile phase: acetonitrile-buffer (TEAA 1% w/v)
ml/min. The L enantiomer eluted first.

3ono v/v, 1
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that part of the k' difference was due to the mobile phase composition
(Table VIII).
The size of the molecule was also an important parameter in chiral
recognition by CD. If the molecule was too big to fit inside the CD cavity,
chiral recognition was hindered. This was the case for norgestrel. The
two isomers of this steroid were not separated by the

~-CD

bonded

column. The chiral center of norgestrel was part of a ring and has an sp
hybridized carbon atom. Although there is no aromatic ring in this
molecule, it should be possible to obtain a chiral separation on CO-bonded
CSPs. Figure 20 shows the separation obtained on a y-CD-bonded column.
y-CD has eight glucose units and a larger cavity that can accommodate
steroids.
Figure 21 is the circular dichroism spectrum of the two peaks obtained
with huperzine A. Huperzine A was injected five times and its first and
second peaks were collected in two different vials. The circular dichroism
of each collected peak was obtained using a Jasco 1600 polarimeter. The
two circular dichroism spectra were superimposed in Figure 21. For any
wavelength, the circular dichroism of the first peak was opposite to the one
of the second peak. This is absolute proof of enantiomeric separations.
However, this experiment did not allow the determination of the absolute
chemical configuration of the enantiomers. Indeed, the D and L structures
are not systematically linked to a positive or negative light polarization
rotation.
Triethylammonium acetate (TEAA) was added at relatively high
concentration (0.062 M or 1% w/v) in the aqueous fraction of the mobile
phases to decrease the retention and to improve the efficiency of amino
compounds. Basic amino groups have a high affinity for the hydroxyls on
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Figure 21. Circular dichroism superimposed spectra of peak 1 and peak 2
obtained with huperzine A.
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the COs. This may produce high retention times and peak tailing. The
addition of 1% , (w/v), of TEAA to the mobile phase can solve this
problem; the TEA+ ions bind to the silanol groups thereby producing
sharper peaks for amino compounds (41 ). Figure 22 shows the evolution
of the separation of the etomidate enantiomers. The use of a diethylamine
(DEA, 0.01 %, v/v) solution (95% and 5% acetonitrile, v/v) produced an
even better separation. With two columns in series using the TEAA
buffer, the separation and resolution factors were 1.46 and 0.90,
respectively (Fig. 22A). With only one column and the DEA mobile phase,
the separation and resolution factors were 1. 70 and 1.30 respectively (Fig.
22B). It must be noted that the pH of the DEA mobile phase was 9.5. This
high pH value could damage the column irreversibly by dissolving the
silica, cleaving some Si-C bonds and releasing the bonded CDs. However,
for short periods of time (as in this separation), it is sometimes
advantageous to use mobile phases at higher pH values.
These phases are able to resolve enantiomers that cannot be separated
by the traditional native CD stationary phases. The use of CSPs in LC is a
new technology that can dramatically improve the quality of chiral drugs
(1 04 ). A full clinical study of the pharmacological and toxicological

effects on both enantiomers of any new chiral drug may soon be required
to obtain an authorization for marketing the drug as a racemic mixture.
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Figure 22. Separation of R and S etomidate. A: two 25 em Cyclobond I
columns connected in series; mobile phase: buffer (1% TEAA,
pH=7)/acetonitrile (90/10 v/v), 0.9 ml/min. B: one 25 em Cyclobond I
column; mobile phase: water (0.01% v/v diethylamine, pH=9.5)/ acetonitrile
(95/5 v/v), 0.8 ml/min.
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E. DERIVATIZED CYCLODEXTRIN IN NORMAL PHASE HPLC

Several different derivatized

~-cyclodextrins

were synthesized and

used as chiral stationary phases in normal phase liquid chromatography
(See Figure 23). The multiply substituted derivatives were made with
acetic anhydride, (R)- and (S)-1-(1-naphthyl)ethylisocyanate, 2,6dimethylphenylisocyanate and p-toluoyl chloride. The first successful
cyclodextrin-based, normal phase separation of enantiomers was
accomplished on these derivative phases. In contrast to chiral separations
on the native

~-cyclodextrin

stationary phase, the enantiomeric separation

mechanism on these new phases is not thought to be dependent on inclusion
complexation. The similarities and differences between the derivatized
cyclodextrin stationary phases and the cellulosic stationary phases will be
discussed.
~-Cyclodextrin

has 21 hydroxyl groups available for modification.

The seven primary 6-hydroxyls are at the "base" or narrow end of the CD
torus while the fourteen secondary 2- and 3- hydroxyl groups are at the
"mouth" or wide end of the CD torus. Also, the CD was attached to silica
gel via its hydroxyl groups through an average of two linkage chains. In
order to obtain the maximum degree of substitution per cyclodextrin, a
large molar excess of derivatizing agent was used under vigorous
conditions. The average degree of substitution for naphthylethylisocyanate
was- 6; 10, for 2,6-dimethylphenylisocyanate and 13.for p-toluoyl
chloride. Acetyl modified ~-CD was thought to be about 90% substituted.
Figure 24 is an idealized model of toluoyl derivatized ~-CD. With the
exception of the acetyl modified cyclodextrins, the new derivatized CD
phases were not exhaustively derivatized and therefore have residual
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Figure 23. Derivatized cyclodextrin utilized as chiral stationary phases.
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Table IX. List of Bonded Sorbents

Amount
of
Derivatizing Agent

Reagent

%C

Units/CD

dimethylphenylisocyanate

5g

7.87

10

p-toluoyl chloride

5g

8.33

13

(R)-(-)-1-(1-naphthyl)ethylisocyanatea

3g

7.58

6.6

(S)-(+)-1-( 1-naphthyl)ethylisocyanatea

3g

8.89

6.3

a The (R)- and (S)-naphthyl derivatized phases were prepared from

different lots of CD bonded sorbent. The difference in %C between the
two phases may reflect the lot to lot substrate variation in surface area, etc.
However, the degree of substitution is calculated from

degree of substitution

= (J..Lmolesfm2 of naphthyl)/(J..Lmoles/m2 of CD)

which eliminates the variation due to surface area.
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chirally selective hydrogen bonding sites as well as additional hydrogen
bonding sites and aromatic groups for 1t-1t interactions. It appeared that
cyclodextrins modified with the larger, bulkier substituents consistently had
a lower degree of substitution. Presumably, this was because of steric
reasons. Lower degrees of substitution could be obtained by using less
derivatizing agent and shorter reaction times. An (S)-naphthylethyl
isocyanate derivatized ~-CD stationary phase, with degree of substitution of
3, (DS-3) was made in this manner. In comparing the DS-3 and DS-7 (S)naphthylethyl isocyanate

derivatized-~-CD

phases, it was noted that under

identical conditions, a solute's retention time increased as the degree of
substitution increased. However, the selectivity (a) did not change
appreciably for most compounds, provided that low levels of analyte were
used.
Most of the prior work done with CD has been in the reversed-phase
mode but recent developments with derivatized CD columns utilized the
normal-phase (NP) mode. In the presence of nonpolar solvents (such as
hexane-isopropanol mixtures) it may be difficult for trace organic solutes
to form traditional inclusion complexes with cyclodextrins because the
hydrophobic cavity is presumably filled with the nonpolar solvent and the
probability of the formation of an inclusion complex is much lower than in
reversed-phase. However, the presence of aromatic and carbonyl groups in
modified COs provide opportunities for 1t-

1t

interactions that do not exist

with native cyclodextrins. This, combined with the hydrogen bonding sites
of the residual hydroxyl groups, provide the type of interactions commonly
associated with Pirkle-type chiral stationary phases ( 105). Furthermore,
the nonpolar solvents do not compete with the solute for the residual
hydrogen bonding sites on the cyclodextrin.
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The first successful CO-based, nonnal phase separation of enantiomers
was accomplished using derivatized CD-CSP. Figure 24 shows a simplified
model of toluoyl derivatized ~-CD chiral stationary phase. Table X lists
twenty different enantiomeric compounds that were resolved on one or
more of the derivatized cyclodextrin stationary phases. Seven of these
racemic compounds (Nos. 13,14 and 16-20) also could be resolved on
native ~-cyclodextrin columns in the reversed-phase mode (31, 106), but
the rest of the compounds could not. For the compounds that were
resolved on both types of columns, the selectivity (a) obtained on the
derivatized ~-cyclodextrin columns was comparable or better (and with
smaller k'-values) than that obtained on the native

~-cyclodextrin

columns.

Also, it should be noted that for compounds 18, 19 and 20, two
conventional ~-cyclodextrin columns (a 25 em and 15 em column ) used in
series were required to obtain similar selectivity.
Occasionally, two different modified CD columns could resolve the
same racemate (see Nos 3-6; Table X). Figure 25 shows the nonnal phase
separation of compound No. 4 on two different derivatized ~-CD columns.
Note the retention and resolution characteristics were significantly
different. All racemates were tested under a variety of conditions on all of
the modified CD columns. Each derivatized-CD seemed to have a distinct
enantioselectivity. Several of the compounds were highly selective for one
particular stationary phase (Table XI). The seemingly random selectivities,
column efficiencies and mobile phase requirements of the derivatized CD
column were analogous to those reported for the modified cellulosic chiral
stationary phases (107). In general, the isocyanate-derivatized phases
seemed to have the best selectivity. The resultant carbamate linkage of the
isocyanate-derivatized phases may provide additional sites for hydrogen
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Figure 24. Simplified model of toluoyl derivatized P-cyclodextrin.
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Figure 25. Comparison of toluoyl and peracetylated

~-CD

CSP for the

normal phase separation of (R,R)-(S,S)-N,N'-bis-(a-methylbenzyl)sulfamide. The mobile phase was 90/10 (v/v) hexane/isopropanol and the
flow rate was 1.0 ml/min. The conditions were the same for the two
chromatograms, the only difference was the stationary phase used.

Table X Normal Phase LC separation data for a variety of Enantiomeric solutes on
Bonded Derivatized ~-Cyclodextrin columns
Compound

Structure

~

1. (±)-y-phenyl-ybutyrolactone

2. N-(dinitrobenzoyl)2-amino-2,3-dimethyl
butane

3. (±)-phensuximide

4. (R,R)-(S,S)-(±)-N ,N'-

bis-(a-mcthylbenzyl)sulfamide

@-~

N02

N0 2

yll
-Nll-y..l.. CH-CHJ

a.

Mobile Phasea

Stationary Phase

1.10

98:2, hex:ipa

2,6-dimethylphenylisocyanate

5.87

1.20

90:10, hex:ipa

R-naphthylethylisocyanate
derivatized P-CD

5.60

1.15

90:10, hex:ipa

2,6-dimethy\phcny\isocyanate derivatized

k'1

14.5

cu 3 tH 3

'~

~-CD

3.38

1.07

90:10, hex:ipa

R-naphthylcthylisocyanate
dcrivatized-P-CD

4.33

\.21

90:10, hex:ipa

pcracctyl dcrivatized-P-CD

5. (R,S)-N-trichloroacetyl1,2,3,4-tetrahydro-1naphthylamine

6. D,L-3-(o.-acetonyl-4chlorobenzyl)-4hydroxycoumarin

9
OOCClJ

@(l

2.13

1.08

90: 10, hex:ipa

toluoyl derivatized-P-CD

7.70

1.3

95:5, hex:ipa

2,6-dimethylphenylisocyanate
derivatized-P-CD

1.28

1.06

90:10, hex:ipa

R-naphthylethylisocyanate
derivatized-P-CD

23.6

1.12

70:30, AcN:ipa

R-naphthylethylisocyanare
derivatized-P-CD

21.5

1.13

60:40, hex:ipa

peracetyl derivatized-P-CD

1.27

99.5:0.5,
EtOH:HoAC

toluoyl derivatized-P-CD

1.1

95:5, hex:ipa

2,6-dimcthylphcnylisocyanate
derivatized-P-CD

0

"t~F"';"',
Cl

7. (R,S)-o.-methoxyphenylacetic acid

8. (R,S)-2-methoxy-2phenylethanol

4.5

H

0~
;2115

9. (±} glutethimide

10. N-CBZ-DL-proline

14.3

1.1

@-cu2 o-~·o

00

@fll)

CII-NH-NII-C-C-NII2

12. (R,S)-N-(3,5-dinitrobenzoyl)-a.-methyl
benzyl amine

NOk

13. N'-benzyl nornicotine

eyO~

0

2,6-dimethylphenlisocyanate
derivatized-~-CD

3.1

1.08

90:10, hex:ipa

toluoy1 derivatized-~-CD

13.3

1.16

99.9:0.1,
EtOH:HOAc

R-naphthylethylisocyanate
derivatized-~-CD

OCOOH

11. (±)-5-(a.-phenethyl)semioxamazide

90:10, hex:ipa

Cll v;:::\\

'}::!./~-NII- CII-&

3.31

1.03

90: 10, hex:ipa

peracetyl derivatized- ~-CD

6.2

1.6

70:30, hex:ipa

2,6-dirnethylphenylisocyanate
derivatized-~-CD

No 2

2.61

1.18

98:2, hex:ipa

R-naphthylethylisocyanate
derivatized-P-CD

4.4

1.13

98:2, hex:ipa

R-naphthylethylisocyanate
derivatized-P-CD

I

N

:::,...

14. N'-(2-naphthylmethyl)
nornicotine

crm
:::,...

h

\0
-..]

15. (R,S )-2,2•-bi-2-nnphthol

~H

23.4

1.10

98:2, hex:ipa

2,6-dimethylphenylioscyanate
derivatized-~-CD

O(YH
2.6

1.2

95:5, hex:ipa

R-naphthylethylisocyanate
derivatized-P-CD

17. (R,S)-2,2 -binaphthyldiyl-17-thiacrown 5

5.2

1.08

95:5, hex:ipa

toluoyl derivatized-J3-CD

18.

2.9

1.06

98:2, hex:ipa

R-naphthylethylisocyanate

16. (R,S)-2,2•-binaphthyldiyl-.
crown 4

1

00\n,l
~

derivatized-~-CD

19.

4.20

1.07

98:2, hex:ipa

R-naphthylethylisocyanate
derivatized-P-CD

20.

1.07

98:2, hex:ipa

R-naphth ylethy Iisocyanate
derivatized-~-CD

a hex is the abbreviation for hexane and ipa is the abbreviation for isopropanol.
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bonding and/or stronger dipole-dipole interactions relative to the ester
linkage of the acid chloride-derivatized phases. The naphthylethylisocyanate derivatized ~-CD columns had a definite logic for the separation
of at least one group of compounds. Solutes that contain an aromatic 7tacidic group and an amide, urethane or urea group usually were resolved.
Derivatization of analytes (such as chiral amines, alcohols, carboxylic
acids, etc.) by the addition of a 3,5-dinitrobenzyl group expanded the
range of compounds which could be separated by providing additional sites
for interaction with the chiral agent. In this respect, the
naphthylethylisocyana te derivatized-CD phase was somewhat analogous to
the naphthylvaline reciprocal CSPs developed by Pirkle and Pochapsky
(1 08).

As has been noted, there are a number of analogies that can be drawn
between the derivatized cyclodextrin bonded phases and modified cellulosic
phases. For example, both are modified carbohydrates containing glucose
monomer units. Many of the substituents attached to the 2-, 3- and 6hydroxyl groups of cellulose and cyclodextrins are identical (i.e., acetyl
and toluoyl) or analogous (i.e., the aromatic isocyanates). However, there
are a number of important differences in these two classes of chiral
stationary phases which can significantly affect the chromatographic
approach and results. A comparison of these two classes of CSP is given in
Table XI. One of the obvious differences is that the derivatized
cyclodextrins are discrete molecules covalently bonded to silica gel while
the cellulosic CSPs consist of a distribution of polymers that are adsorbed
onto silica gel. As a result, the cellulosic phases are limited to fairly large
pore-size silica gels (e.g., > 300A), so that the cellulose polymer can go
into the pores and coat the internal surface) while the

I0 I

Table XI. Compariso n of Derivatized Cyclodext rin
and Derivatize d Cellulosic Chiral Stationary
Phases for Normal Phase LC Separation
Derivatized Cyclodextrin
1. Individual molecules
covalently bonded to silica gel.

Derivatized Cellulose
I. Distribution of polymers
adsorbed on silica gel.

2. No solvent restrictions except
for strong acids and bases.

2. Must avoid halogenated solvent
or any other mobile phases that
will dissolve and remove the
substituted cellulose.

3. Can be stored at room
temperature indefinitely in typical
nonnal phase solvents. No
irreversible conformationa l
changes that affect chiral
recognition are possible.

3. Storage recommended hexane
at -4 °C. Upon standing at room
temperature, polar organic
modifiers (isopropanol, etc.)
sometimes can cause an alteration
in the secondary structure of
adsorbed cellulose polymers
resulting in a loss of chiral
recognition.

4. Can be bonded to a variety of
different pore-size silica gels (60-

4. Must be adsorbed on a large
enough pore size silica gel
(-300A) that the polymer can
enter the pore.

300A).

5. Highly purified derivatives can
be crystallized thereby allowing
computer modeling and
theoretical evaluation of
enantioselectiv e properties.

5. Cannot be crystallized at the
present time. Secondary structure
that contributes to enantioselectivity is unknown.

102

derivatized -CD CSPs are not. At least two precautions must be observed
with the coated chiral stationary phases that are unnecessary with bonded
varieties. For example, mobile phase solvents that dissolve the polymer
(such as halocarbon s, THF, etc.) must be strictly avoided for the cellulosic
CSPs as they quickly strip the derivatized cellulose from the silica gel.
Also, there seems to be a definite secondary structure to the adsorbed
cellulose polymer which leads to chiral recognition. If this secondary
structure is altered or changed, enantioselectivity could be lost even though
the chiral polymer remains on the silica gel. Storing these columns in
mobile phases containing a more polar solvent (such as isopropanol) at
room temperatur e was sometimes sufficient to cause a change in the
secondary structure of the polymer.
Despite the empirical similarities between the derivatized cyclodextrin
and derivatized cellulosic stationary phases, they do not have identical
enantiosele ctivities. There were racemates that have been resolved on the
derivatized -CD columns that have not been resolved on the analogous
cellulosic phases (e.g., compounds 5 and 19 of Table X) and vice versa.
Other racemates could be resolved on both phases thereby giving one a
choice. Having such a choice frequently is useful since the efficiency,
selectivity, loading capacity, retention time, optimal solvent composition,
cost, etc. usually differ for different CSPs.
As the number of available chiral stationary phases increases, there is
bound to be overlap in the types of compounds separated. Clearly, more
studies need to be done comparing many of the existing columns. This is
likely to occur in the near future.
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F. AMINO ACID STUDY

The column switching set-up for this study is shown in Figure 26.
The general racemization profile versus pH for many free amino acids is
illustrated in Figure 27. Typically there are minima between pHs of 0 to 3
and a plateau region between pHs 3 to 7 (1 09). At very high (> 12) and
low(< 0) pHs, the rate of racemization increases substantially. In addition
to pH, racemization rates also are influenced by temperature, ionic
strength, presences of metal ions and so forth. Each amino acid has an
individual racemization profile and rate. Aspartic acid, for example, has a
small maximum at pH - 3.8 and another minima at pH - 5.0 (1 09). One
goal of the analytical methodologies developed for this work was to
minimize the effect of racemization on the measured enantiomeric purities.
Hence most samples were analyzed immediately after they were obtained.
The analyses were complete within 45 minutes from sample introduction.
No pH or temperature extremes that could lead to high racemization rates
were used at any time. No precolumn reaction or derivatization of the
amino acids were done (see Materials and Methods).
Each analytical system was "tested" with commercial L-amino acid
preparations. Typical results for five amino acids are shown in Table XII.
D-amino acids were found in all commercial samples although some were
at very low levels. Clearly, analytical methodologies for detennining
enantiomeric purities are reaching high levels of sophistication and
sensitivity. In many cases the sensitivity is such that an enantiomeric
impurity is almost always found (Table XII). Of the L-amino acids
evaluated, tryptophan usually had the lowest levels of the "unnatural" Damino acid. It was not unusual to see tenths of a percent and occasionally
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Figure 26. Schematic showing the coupled column (i.e., achiral-chiral)
system used for the determination of the enantiomeric purity of amino acids
in urine. Note, when electrochemical detection was used (detector 2) there
was no post-column derivatization. When fluorescence detection was used

(detector 2), post-column OPA derivatives of the amino acids were made.
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Figure 27. Plot showing the rate of L:D interconversion versus pH for
phenylalanine and leucine at 142°C. Data redrawn from Bada (1985).

Table XII. Data Showing the Amount of Contaminating D-Enantiomers in Commercial
Samples of L-Amino Acids
Sample
Source

Cysteine

Ornithine

%Da

Methionine
%Da

A. Fluka

2.9 X 10-1

4.2 X 10-3

1.7 X 10-3

3.6 X 10-2

1.9 X 10-3

B. Kodak

8.0 X 10-1

6.0x 10-3

7.6 X 10-2

2.1

10-2

5.7 X 10-3

C. Lancaster
Synthesis

3.9 X 10-1

5.0 X 10-3

3.9 X 10-1

6.5 x 1o-3

8.9 X 10-4

D. Sigma

4.1

X

10-1

3.5 X 10-2

2.9 X I0-2

7.3

X

10-3

E. Spectrum

6.5

X

10-1

3.0 X lQ-2

1.5 X 10-3

1.0

X

IQ-3

3.3

3.8 x 10-1

%Da

Tyrosine
%Da

X

Tryptophan
%Da

a% D denotes the% D-amino acid enantiomer present in the commercially available L-amino acid samples. All samples were prepared
immediately prior to analysis. Conditions for separation are indicated in the experimental section.

-
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percent levels of the D-enantiomers. There were significant batch to batch
differences in the enantiomeric purity of individual amino acids from the
same company. These variations often were as great as the variations
between companies (Table XIII). It might be interesting to consider the
effect that the varying levels of enantiomeric impurities could have on
some of the numerous biological, biochemical and medicinal experiments
that utilize these amino acids. Figure 29 shows the chromatographic
separation of D-cysteine and D-tryptophan from the dominant Lenantiomer in two commercial samples.
Several essential amino acids were analyzed in human urine, blood
serum and amniotic fluid. Because of the large number of contaminating
compounds and high ionic strength, it was not advisable to directly inject
biological samples onto a chromatographic chiral stationary phase (CSP).
A column switching procedure was essential for accurate results and for
increasing the longevity of the CSP. The amniotic fluid samples were
much cleaner than the urine and the blood serum samples but the same
precautions were taken. The fresh sample was directly injected onto a
reversed phase C18 column which separated the amino acids from one
other as well as from the other compounds in the sample. Figures 29, 30
and 31 show typical C18 chromatograms of urine, blood serum and
amniotic fluid, respectively. Upon elution, the amino acid of interest was
then switched onto the CSP for enantiomeric resolution and quantitation.
Figure 32 shows the enantiomeric separation of phenylalanine from human
urine on a chiral crown ether column ( 11 0). Figure 33 shows the
enantiomeric separation of tyrosine from human blood serum utilizing the

same column. Some amino acids can be detected directly by
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Figure 28. LC chromatograms used to evaluate the enantiomeric purity of
L-cysteine from Fluka and L-tryptophan from Sigma. Electrochemical
detection was used in both cases. For chromatogram A, the mobile phase was
pH 1.5 aqueous HCl04; the flow rate was 0.1 ml/min; the voltage was +0.50v
and the gain was 1x50. For chromatogram B, the mobile phase was pH 1.5
aqueous HCI04; the flow rate was 0.8 ml/min; the voltage was +0.50v and
the gain was 10x5.
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Table XIII. Batch Comparison for L-amino acids
from company D
Amino Acid

%Din Batch 1

%Din Batch 2

Cysteine

0.405

1.109

Methionine

3.35

2.32

Tyrosine

0.029

0.029

Tryptophan

0.073

0.038

Note: Batch 2 material was ordered in preparation for the commercial
study. Batch 1 material was on the lab shelf prior to preparation for the
commercial study.
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Figure 29. A C18 chromatogram for the direct injection of urine. Peaks for
four amino acids (Leucine, tyrosine, phenylalanine and tryptophan) are
indicated. UV detection at 200 nm was used. The injection volume was 20

ml, the flow rate was 1.5 ml/min and the mobile phase consisted of 5:95 (v:v)
methanol:5xl0-3M HCl04. Note: in this chromatogram the peak labeled
tryptophan actually consists of tryptophan plus another impurity. However,
these two components are resolved when using a mobile phase consisting of
5:95 (v:v) methanol:water.
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Figure 30. A C18 chromatogram for the direct injection of blood serum.
UV detection at 200 nm was used. The injection volume was 20 J.il, the
flow rate was 1.0 ml/min and the mobile phase 5:95 (v:v) MeOH:H20.
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Figure 31. A C18 chromatogram for the direct injection
of amniotic fluid.
UV detection at 200 nm was used. The injection volume
was 20 ~1, the
flow rate was 1.0 mVmin and the mobile phase 5:95 (v:v)
MeOH:H20.
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electrochemical detection, while others must undergo postcolumn
derivatization to form a fluorescent analogue (see Experimental Section).
Table XIV summarizes the analytical data for four of the amino acids
found in human urine. The total levels of these amino acids were within
ranges previously reported for human urine (Ill). Trace levels of the
"unnatural" D-amino acids were found in all cases. The relative amounts
of D-amino acids present in these samples ranged from several hundredths
of a percent to percent levels (Table XIV). In general, there were greater
amounts of D-amino acids found in human urine than were found in
commercial standards for L-amino acids (Table XII). The range of total
amino acid concentrations as well as the percent 0-enantiomer content
varied not only from person to person but also for one person from day to
day. For example, in the case of the phenylalanine data in Table XIV, both
the high (5.1%) and low (0.3%) values came from two different specimens
provided by the same individual two weeks apart. In general, the relative
amount of 0-phenylalanine was greater than that found for 0-tyrosine and
D-tryptophan. There did not seem to be a correlation between the total
amino acid concentration in urine and the relative amount of the Denantiomer.
In order to quantitate the low levels of 0-amino acids, relatively large
samples (20 - 200 J.ll) had to be injected. If amino acid levels were too
low, a preconcentration step was necessary. This was the case for some of
the amino acids not reported in this work. Although preconcentration
increased the level of the trace analyte in a given volume of sample, it also
increased the level of interfering contaminants. This could lead to
overlapping peaks or column overloading and poor resolution.
Lypholization seemed to be the most effective way to
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Table XIV. Summary of Free Amino Acid Data
from Human Urine Specimens
Number of Urine
Amino Acid

Samples Analyzed

Total Range of AA

% D-Amino

Concentration mMIL Acid, Range

Average%
D-Amino Acid

Phenylalanine

11

35 - 130

0.3- 5.1

Tyrosine

9

45 - 210

0.1-0.?a

Tryptophan

8

46- 280

0.06- 0.4

0.2

Leucine

3

b

b

b

1.9

aone result (i.e., 6.6% D-tyrosine) was excluded from this data as it was
approximately an order of magnitude higher than the next closest value.
Four different individuals provided all samples for this study. However,
the high tyrosine value (vide supra) was the sole sample provided by one
individual. Currently, it is not known if this high value is legitimate or is
due to an impurity or some other error.
bpeaks were obtained for both the D- and L-leucine. However, neither
peak was baseline resolved from other contaminate peaks. This made
accurate quantitation difficult. Although we are reasonably confident that
some D-leucine is present, we would prefer to improve the analytical
methodology somewhat before reporting any numbers.
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concentrate excreted amino acids. Solid phase extraction of amino acids
from urine proved to be ineffective. Solid phase extraction of amino acids
was performed with the blood serum samples to remove proteins. Table
XV compares the measured levels of D-tryptophan and D-tyrosine in
lypholized urine samples versus untreated urine samples that were analyzed
directly. The lypholization step did not affect the measurement of Dtryptophan in urine. However,the apparent amount of D-tyrosine in
lypholized urine was anomalously high (Table XV). This was thought to
be the result of overlapping impurity peaks rather than to racemization

during lypholization. However, further investigations must be completed
before racemization can be completely disregarded.
Table XVI summarizes the analytical data for three of the essential
amino acids found in human blood serum. The total levels of these amino
acids were within ranges previously reported for human blood serum.
Trace levels of D-amino acids were found in some cases. The relative
amounts of D-amino acids were lower than that reported for human urine.
Each person donated a single sample, so individual variations were not
studied. The lowest concentration of D-amino acid was found for
phenylalanine and the highest concentration was for tyrosine. No
"unnatural" 0-amino acids were detected in the amniotic fluid samples for
the four amino acids analyzed. The limit of detection was 0.05%.
This study provides evidence for the presence of free 0-amino acids
in human urine and blood serum. In some cases the "unnatural" Denantiomer was present at percent levels relative to the corresponding Lamina acid concentration. However, somewhat lower levels were more
common. Care must be taken to resolve the amino acids of interest from
other similarly retained components so as not to overestimate the amount

Table XV. Data Showing the Effect of a Freeze-Drying Preconcentration Step on the
Measurement of D-Amino Acid Levels.

Amino Acid

Range of D-Amino Acids
Perconcentration by
Direct Injection
lypholization

Average % D-Amino Acid Concentration
Preconcentration by
Direct Injection
lypholization

Tryptophan

0.1 - 0.36

0.06- 0.6

0.18

0.21

Tyrosine

0.1 to 0.70

3.0 to 9.2

0.3

4.8

--
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of the D-enantiomer. Any biochemical, physiological or clinical
significance of these enantiomers has yet to be established. Certainly there
are a number of interesting possibilities. Many past studies on the
efficiency of free amino acid reabsorption by the kidney have not taken
into account possible differences in the rates or mechanism of D- versus Lamino acid absorption, for example.
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Table XVI. Summary of free amino acids data
from human blood serum samples
Number of Urine
Amino Acid

Samples Analyzed

Total Range of AA

% D-Amino

Concentration mM/L Acid, Range

Average%
D-Amino Acid

Phenylalanine

13

35 - 130

<0.05-1.00

0.10

Tyrosine

8

45- 210

<0.05-0.51

0.31

Leucine

4

a

<0.05

<0.05

a Same as Table XIV.
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Figure 32. Chromatogram showing the enantiomeric purity of
phenylalanine from the direct injection of a urine sample onto the coupled
column system (Figure 26). The conditions for the C18 separation were the
same as in figure 29. Note the absence of interfering peaks. A chiral crown
ether column was used at room temperature. The mobile phase consisted of
0.02 M HC104, and the flow rate was 0.5 ml/min. Fluorescence detection
was used after post column OPA derivatization (see experimental).
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Figure 33. Chromatogram showing the enantiomeric purity of tyrosine
from the direct injection of a human blood serum sample onto the coupled
column system (Figure 26). The conditions for the C18 separation were
the same as in figure 29. Note the absence of interfering peaks. A chiral
crown ether column was used at room temperature. The mobile phase
consisted of 0.02 M HCl04, and the flow rate was 0.5 mVmin.
Electrochemical detection was used: v=+0.5volts.
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CONCLUSIONS
Chiral mobile phase additives were studied in both normal and reverse
phase thin layer chromatography. N-carbobenzoxy-glycyl-L-proline and
(1 R)-ammonium-1 0-camphorsulfonate were effective CMAs for various

aromatic amino alcohols, but it was not possible to obtain chiral separations
unless the solvents were properly dried. Derivatized ~-cyclodextrins
proved more soluble in hydro-organic solvents than the native ~-CD.
Maltosyl- and hydroxypropyl-~-CD were useful as CMAs but dimethyl-~
CD was not. It was determined that the degree of substitution of the
derivatized CD can effect the viscosity of the mobile phase, the time of
development and the enantioselectivity. In enantiomeric separations
involving CMAs two parameters had to be optimized to develop a plausible
TLC technique. The first parameter was the type of TLC plate utilized and
the second parameter was the mobile phase composition.
Native and derivatized

~-CD

chiral stationary phases were successful in

resolving a variety of chiral analytes in reverse and normal phase high
performance liquid chromatography, respectively. Results indicated that
the enantioselectivity can be different for some compounds when
comparing the different types of derivatized CD columns. The same can be
said of a comparison of the derivatized cyclodextrin and the derivatized
cellulosic stationary phases.
The potential of CSPs based on CDs is tremendous, and recently CD
derivatives that can be used as CSPs in gas chromatography have been
developed (103). Derivatized COs can be used in LC to improve chiral
separations or to extend the applicability of such CSPs. Currently this
research group is completing experiments on the use of derivatized COs as
stationary phases for both reversed and normal-phase LC.
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In a comparison between the L-amino acid product of six prominent
companies, the range of D-amino acid impurity was from 1.0 x Io-1 to 8.9
x I0-4%. Although the human body is known to be composed of L-amino
acids, experimental results indicated that there are trace to percent levels of
D-amino acids in blood serum and urine. There were no detectable levels
of D-amino acids found in human amniotic fluid.
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